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ABSTRACT
ASSEMBLY AND FUNCTIONAL ARCHITECTURE OF BACTERIAL
CHEMORECEPTOR NANOARRAYS
FEBRUARY 2018
ELIZABETH R. HAGLIN, B.S., SIMMONS COLLEGE
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Lynmarie K. Thompson
Transmembrane chemotaxis receptors are found in bacteria in extended hexagonal
arrays stabilized by the membrane and by cytosolic binding partners, the kinase CheA
and coupling protein CheW. Models of array architecture and assembly propose receptors
cluster into trimers-of-dimers that associate with one CheA dimer and two CheW
monomers to form the minimal "core unit" necessary for signal transduction.
Reconstructing in vitro chemoreceptor ternary complexes that are homogenous,
functional, and exhibit native architecture remains a challenge. Here we report that Histag mediated receptor dimerization with divalent metals is sufficient to drive assembly of
native-like functional arrays of a receptor cytoplasmic fragment. Our results indicate
receptor dimerization initiates assembly and precedes formation of ternary complexes
with partial kinase activity. Restoration of maximal kinase activity coincides with a shift
to larger complexes, suggesting that kinase activity depends on interactions beyond the
core unit. We hypothesize that achieving maximal activity requires building core units
into hexagons and/or coalescing hexagons into the extended lattice. This discovery may
also address a previously observed density-dependent transition between signaling states.
To further test this, we implemented a paramagnetic relaxation enhancement (PRE) based
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solid-state NMR approach to obtain long-range (≥ 20 Å) distance constraints across the
trimer of dimers interface. Overall, the work presented here shows that minimally
perturbing His-tag mediated dimerization promotes assembly of chemoreceptor arrays
with native architecture, and thus enabled us to gain insights into the mode of array
assembly and the role of the core functional unit.
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CHAPTER 1
BACTERIAL CHEMOTAXIS AND OVERVIEW OF THIS STUDY
1.1. Introduction
As gatekeepers of the cell, membrane proteins are crucial players in cellular
homeostasis. Many bacteria and archaea rely on transmembrane proteins that govern
signal transduction pathways to sense and adapt to their environment. One such pathway,
the chemotaxis system, enables motile bacteria to track chemical gradients of attractants
or repellents by transmitting information about the extracellular chemical environment to
the flagellar motor in order to alter swimming direction. The membrane proteins
responsible for this process, called chemoreceptors or methyl-accepting chemotaxis
proteins (MCPs), regulate a histidine kinase CheA. CheA phosphorylates a response
regulator protein CheY, which in turn controls the rotation of the flagellar motor.
Chemoreceptors are typically anchored in the membrane and form stable ternary
complexes with CheA and a coupling protein CheW. Together, these ternary complexes
cluster into exquisitely sensitive and highly ordered polar arrays. Organized as a
hexagonal lattice comprised of trimers of receptor dimers at each vertex, the architecture
is remarkably conserved among bacteria and archaea (Briegel et al., 2009, 2012, 2015).
The chemosensory proteins of Escherichia coli and Salmonella typhimurium are the most
widely and thoroughly studied, due the limited number of components that retain a high
degree of sophistication, and have therefore served as a model system for both
chemotaxis and transmembrane signal transduction research alike. Despite the breadth of
structural and functional knowledge available today, there are still a number of open
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questions including how arrays assemble and influence receptor activity and how signals
are propagated through the receptor cytoplasmic domain (Parkinson et al., 2015).
In this work, we present a novel in vitro assembly method that can be used to
trigger formation of functional and native-like arrays of the aspartate chemoreceptor
cytoplasmic fragment (CF). This method makes it possible to follow the time course of
assembly in a manner that could not previously be done with cryo-electron tomography
(ECT) and with other assembly methods. The results provide an alternative view of the
minimal unit for kinase activity and of a previous proposal that ligand-induced receptor
expansion controls kinase activity. We initiated an NMR-based approach that sets the
stage to obtain long-range distance constraints for the receptor trimer of dimers to test
this proposal and to further define the receptor structure within the native array. Overall,
this study provides a platform to follow assembly and test a proposed signaling-related
conformational change.
This chapter first describes how chemoreceptors and their component proteins
work together to achieve chemotaxis. This is followed by a discussion of the structural
features of chemoreceptors and the remarkable arrays they form. We then outline
methods of assembly needed to generate in vitro chemoreceptor complexes and how
those have and continue to be used to test mechanisms of signal propagation. Lastly, the
key objectives and findings of this study are discussed.

2

1.2. Background
1.2.1. Chemotaxis signal propagation, adaptation, and amplification
Motile bacteria such as E. coli have four to six flagella driven by reversible rotary
motors that are powered by the flux of ions (Berg, 2003). The direction of flagellar
rotation dictates cellular movement. Cells swim forward with counter clockwise (CCW)
rotation, which forms a flagellar bundle to propel the cell forward. Conversely, clockwise
(CW) rotation causes the bundle to fall apart, leading to tumbling in place.
Chemoreceptors localized at the cellular poles detect gradients of attractants (amino acids
and sugars) or repellents (metal ions and acids) that bind to the periplasmic ligandbinding domain. Mutational (Ames and Parkinson, 1988), cysteine-crosslinking (Chervitz
and Falke, 1995), EPR (Ottemann, 1999), and NMR (Murphy et al., 2001; Isaac et al.,
2002) studies indicate that ligand binding induces a 2 Å piston-like motion of one
transmembrane helix relative to the others within the dimer. It remains unclear how this
signal then travels down the length of the cytoplasmic domain to the membrane-distal
signaling subdomain to inhibit the kinase CheA. Since the signaling mechanism is known
in this region, the work presented here focuses on the cytoplasmic domain. Together with
a coupling protein CheW, ternary complexes exhibit kinase-on and kinase-off output
states. As illustrated in Figure 1.1, attractant binding shifts the receptors to the kinase-off
state, which in turn slows the flux of CheA phosphoryl groups (yellow circles labeled “P”
in Figure 1.1) to the response regulators CheY and CheB. Phospho-CheY carries the
signal to flagellar motor proteins, which subsequently induce CW rotation, leading to the
cell tumbling in place.
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Figure 1.1. The chemoreceptor signaling pathway in E. coli. For simplicity, the fulllength receptors (MCPs) are shown as single homodimers (monomers colored gray and
black). In their native architecture, receptors form trimers of dimers in complex with the
kinase CheA (blue when active) and CheW (cyan) (see Figure 1.3). Components shown
in red reduce CheY-P levels and promote counter clockwise (CCW) flagellar rotation and
a swimming response; those in green enhance CheY-P and lead to clockwise (CW)
rotation and cellular tumbling. The small circles on receptor dimers indicate unmodified
(white) or methylated (green) adaptation sites. The fully methylated receptor can be
mimicked through mutations of the four sites to Glu (Q) in intact receptors or
cytoplasmic fragments (CF).
The exquisite sensitivity and large dynamic range of signal detection (10–7–10–3
M) (Adler, 1969) is partly mediated through a sensory adaptation that effectively resets
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the ON–OFF equilibrium to a pre-stimulus level. This is accomplished by covalent
modification of several glutamyl residues located in the methylation subdomain of the
receptor (Figure 1.2, white and green circles) (Springer et al., 1979). Ligand binding
shifts the receptor to the kinase-off state and also increases the rate of methylation by the
methyltransferase CheR, causing an immediate (~sec) decrease in tumbling frequency.
Adaptation then occurs in minutes, when methylation shifts the receptor back toward the
kinase-on state and resets the ligand affinity (Springer et al., 1979). Likewise, a
methylesterase CheB—activated by the kinase-on state via phosphorylation by CheA—
hydrolyzes the receptor glutamyl ester to glutamic acid, resulting in a shift toward the
kinase-off state. Both CheR and CheB are recruited to the receptor by a penta-peptide
(NWETF) sequence on the flexible C-terminal tail (Wu et al., 1996).
In the cell, signal transmission is amplified across interconnected and extended
arrays of chemoreceptors. Remarkably, attractant binding to one receptor can regulate
roughly 35 kinases within the array (Sourjik and Berg, 2002), Moreover, the attractant
response is highly cooperative with Hill coefficients (nH) of 10–27 observed (Li and
Weis, 2000; Sourjik and Berg, 2004; Han and Parkinson, 2014), depending on the
preparation, receptor type, and methylation state. This indicates a high level of cross talk
between receptors and/or CheA and CheW, and suggests that receptors operate in concert
as allosteric arrays. Large polar patches of ternary complexes have been widely reported
in cells by fluorescence imaging (Maddock and Shapiro, 1993; Gestwicki et al., 2000;
Sourjik and Berg, 2000; Kentner and Sourjik, 2006) and electron cryotomography (ECT)
(Zhang et al., 2007; Briegel et al., 2012; Liu et al., 2012). Furthermore, chemoreceptor
arrays exhibit similar architecture among a diverse set of species, indicating a universally
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conserved mechanism of receptor clustering (Briegel et al., 2009, 2015). Given the
cooperativity and arrangement, it’s likely that interactions within the arrays are critical
for function.

1.2.2. Structural features of chemotaxis receptors and their complexes
A considerable amount of structural information has been collected on soluble
fragments and full-length forms of the chemotaxis proteins. Both X-ray and NMR
structures have been deposited in the Protein Data Bank (PDB) for chemotaxis proteins
and protein fragments originating from a number of species. We therefore have a broad
understanding of many structural features for each of the chemosensory proteins.
Chemoreceptors are intertwined transmembrane homodimeric proteins that are
rod-shaped and predominantly α-helical. In addition to high-resolution x-ray structures of
chemoreceptor fragments, electron microscopy has shown that each intact receptor dimer
is approximately 380 Å long (Wadhams and Armitage, 2004) and oriented perpendicular
to the membrane (Weis et al., 2003). As shown in Figure 1.2A, there are three functional
elements: (1) a periplasmic sensing domain for ligand binding that connects to four
transmembrane helices, (2) a cytoplasmic, membrane-proximal HAMP domain (found in
histidine kinases, adenylyl cyclases, methyl-accepting chemotaxis proteins, and
phosphatases (Aravind and Ponting, 1999)), and (3) a cytoplasmic signaling domain
comprised of methylation, flexible bundle, and protein interaction subdomains.
The x-ray crystal structures of the E. coli Tsr receptor cytoplasmic domain (Kim
et al., 1999) and Thermatoga maritima TM1143 (Park et al., 2006), combined with
mutagenesis studies (Falke and Kim, 2000) have shown that the signaling domain is
predominantly a continuous four-helix, anti-parallel, coiled-coil with a hairpin turn at the
6

membrane-distal tip. The Tsr crystal structure revealed a trimer of receptor dimers
(Figure 1.2B) architecture, which was further confirmed in vivo through cross-linking
(Studdert and Parkinson, 2004; Parkinson et al., 2005). Remarkably, the five E. coli
chemoreceptors share identical trimer contacts, allowing the lower abundance receptors
(Tap, Trg, and Aer) to form mixed trimers with the higher abundance aspartate (Tar) and
serine (Tsr) receptors (Gestwicki and Kiessling, 2002; Studdert and Parkinson, 2004;
Gosink et al., 2006).
Chemoreceptors bind CheA at their membrane-distal tips. CheA is a large
histidine kinase consisting of five domains (P1–P5, domain organization shown in Figure
1.3) that are connected by flexible linkers (Bilwes et al., 1999; Boukhvalova et al., 2002;
Griswold et al., 2002; Wang et al., 2012a, 2012b). The P1 domain contains the histidine
phosphorylation site. The response regulators CheY and CheB dock at the P2 domain.
Dimerization of CheA is mediated through the P3 domain. P4 contains the active site for
ATP binding and phosphorylation of P1. Lastly, P5 binds the receptor and CheW.
Interestingly, P5 and CheW are structurally highly homologous. CheW plays a critical
role in coupling CheA to the receptor to facilitate assembly and signaling, yet its precise
function remains unclear.
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Figure 1.2. Structure of dimeric chemoreceptors. (A) A ribbon model showing the
predominantly α-helical structure of an intact chemoreceptor dimer is was based on
crystal structures of the Tsr cytoplasmic domain (PDB: 1QU7 (Kim et al., 1999)), several
periplasmic domain crystal structures, and a solution NMR structure of Tsr HAMP (PDB:
2ASW) (courtesy of L.K. Thompson). Domain organization and functional regions are
indicated and include: (1) periplasmic sensing domain, (2) HAMP domain, and (3)
cytoplasmic signaling domain, comprised of three subdomains. The methylation sites
within the methylation subdomain are shown in magenta. (B) A structural model of the
cytoplasmic side of the trimer of dimers. This model (provided by A. Briegel, B. Crane,
and G. Jensen) was generated by docking crystal structures of Tsr (1QU7) and ternary
complex fragments (PDB 3UR1) into EM density (Briegel et al., 2012).
Electron cryotomography has shown that chemoreceptor arrays can occupy
membrane surface areas ranging from 12,000 to 144,000 nm2 in different species (Briegel
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et al., 2009). The array features are remarkably similar: hexagonally packed lattices retain
a 12 nm center-to-center spacing in at least 14 species of bacteria (Briegel et al., 2009)
and archaea (Briegel et al., 2015). As previously discussed, chemoreceptor dimers
associate in the membrane into trimers of dimers that are further constrained through
direct contacts with CheA (Wang et al., 2012a; Li et al., 2013; Piasta et al., 2013) and
CheW (Vu et al., 2012; Li et al., 2013; Pedetta et al., 2014) at the membrane-distal tip,
thus forming a ternary complex. As depicted in Figure 1.3, the trimers of dimers reside at
the vertices within a hexagonal lattice, surrounding a ring of alternating CheA regulatory
domains (P5) and the structurally homologous CheW (Bilwes et al., 1999; Griswold et
al., 2002), which form a stabilizing “baseplate”.

Figure 1.3. Receptor core units and hexagonal arrays. A core signaling unit is comprised
of two trimers of receptor (MCP) dimers (gray), one CheA dimer (blue) and four CheW
monomers (cyan). Each CheA monomer has five domains (P1–P5); the two monomers in
the dimer are shown in two shades of blue. A cross section at the receptor tip that is in
line with P3-P5-CheW is rotated 90° to show the top down view (center). Core units
combine to form the proposed architecture of extended hexagonal array (right) with 12
nm center-to-center spacing (black line). The existence of a CheW-only ring (and two
extra CheW in core unit) is currently in debate and discussed in Chapters 3–4.
Due to their highly ordered nature, chemoreceptor arrays are well suited for ECT,
and advances in the technique—including subvolume averaging—have enabled
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incredible three-dimensional images of both near-native cells and well-ordered in vitro
assemblies at macromolecular resolution (~4 nm) (Briegel and Jensen, 2017). Such
images have been used to create structural models of the array by docking crystal
structures into the EM density. In addition to biochemical and high-resolution structural
data, these structural models have significantly improved our understanding of the
hexagonal lattice and its components. For example, a crystal structure of alternating
CheW and CheA-P5 rings bound to receptor fragments (PDB 3UR1) with some rotations
of its components, was fit into EM density, uncovering both the organization of CheA/W
rings with respect to the trimer of dimers, and how CheA-P3 domains link the
neighboring rings together (Briegel et al., 2012). In parallel, Liu and coworkers published
a ~3.2 nm resolution electron density map imaged from in vivo arrays with nearly
identical hexagonal architecture (Liu et al., 2012), which also revealed the existence of
CheW-only rings (Figure 1.3). CheW-only rings have been also been observed by ECT
for in vitro arrays of cytoplasmic fragments assembled onto monolayers (Cassidy et al.,
2015) and are proposed to provide array stability. However, these findings are in contrast
to other studies, which found excess CheW disrupts both kinase activity and trimer
formation (Studdert and Parkinson, 2005; Cardozo et al., 2010). The existence of CheWonly rings is particularly interesting given the discrepancies in the field regarding its role
and stoichiometry in the core unit and the arrays.

1.2.3. Assembly of receptor complexes
Chemotaxis by bacteria has been recognized for more than 135 years (Engelmann,
1881), and has been the focus of intense studies for several decades (Adler, 1966).
Methodologies have expanded from in vivo to a variety of in vitro systems as a way to
10

probe the molecular mechanisms in simplified and controlled environments. A widely
used in vitro preparation consists of native membrane vesicles containing intact
chemoreceptors (Borkovich et al., 1992; Li and Weis, 2000; Falke and Hazelbauer, 2001;
Lai et al., 2005; Erbse and Falke, 2009; Amin and Hazelbauer, 2010). The disadvantages
of these preparations include protein impurities and lack of control over receptor packing
(Lefman et al., 2004) and orientation (Erbse and Falke, 2009). Additionally, recent ECT
studies have shown a high degree of heterogeneity upon in vitro reconstitution with CheA
and CheW to form signaling complexes. Array sizes varied from single trimers (inverted
and outward facing in vesicles) to individual and linked hexagons, and hexagonal patches
exhibiting both 9 nm and 12 nm center-to-center spacing (Briegel et al., 2014a). While
some native functions are at least partly preserved (ligand binding, kinase inhibition,
receptor adaptation), the challenges posed by the heterogeneity of these samples led to
the development of improved assembly methods that recapitulate biological functionality
using purified components in an environment that mimics the native membrane.
Intact chemoreceptor trimers of dimers reconstituted into soluble nanodiscs form
complexes with CheA and CheW that exhibit ligand control of kinase and methylation
activities (Boldog et al., 2006). These ~10 nm nanodiscs are essentially plugs of lipid
bilayers surrounded by an amphipathic membrane scaffold protein (Denisov et al., 2004),
into which inactive, detergent-solubilized intact receptors will insert with random
orientation and regain their function. The nanodisc dimensions prevent incorporation of
more than one trimer of dimers, and maximal kinase activity is observed when receptors
incorporated at levels of ≥ 5 dimers/nanodisc are reconstituted with CheA and CheW. It
is proposed that kinase activity occurs in core units consisting of two trimers of dimers
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(each in a separate nanodisc) that bind one CheA dimer and two CheW monomers (Li
and Hazelbauer, 2011). This 6:1:1 stoichiometry of the core unit is consistent with some
studies, but not others. Moreover, nanodisc assemblies are heterogeneous, with receptors
in both orientations, and they lack the native array.
In an effort to prepare homogenous in vitro complexes that restore the native
array architecture, Weis and coworkers developed templating vesicles to serve as a
membrane mimetic for soluble chemoreceptor cytoplasmic fragments (CF) that do not
assemble into functional ternary complexes without the vesicles (Shrout et al., 2003).
This approach, which has also been extended to lipid monolayers (Cassidy et al., 2015),
utilizes the high-affinity interaction between the CF N-terminal hexahistidine-tag and a
Ni2+-chelating phospholipid (DOGS-NTA-Ni2+). Recent ECT shows these templatingvesicle complexes exhibit native-like hexagonal array architecture (Briegel et al., 2014a).
Alternatively, CF can also be assembled into functional arrays using the molecular
crowding agent PEG (Fowler et al., 2010). The PEG-mediated arrays exhibit a double
layer array of chemoreceptors flanked by two CheA/W baseplates—so-called “sandwich”
arrays, that retain the canonical 12 nm hexagonal spacing. While not native for the
membrane-bound aspartate receptor, some other chemotactic species exhibit cytoplasmiconly sandwich arrays. These have been imaged in Vibrio cholerae (Briegel et al., 2016),
Rhodobacter sphaeroides (Briegel et al., 2014b), and Methanobacterium formicicum
(Briegel et al., 2015).

1.2.4. Current views and hypotheses for signaling mechanisms
The mechanism of signal transduction within the periplasmic and transmembrane
domains is widely thought to involve a 2 Å piston motion (Ames and Parkinson, 1988;
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Ottemann, 1999; Falke and Hazelbauer, 2001; Murphy et al., 2001; Isaac et al., 2002).
Thus, efforts are now focused on understanding signaling mechanisms within the
cytoplasmic domain. Although CF arrays cannot be used to probe the effects of ligand
binding, since the periplasmic, transmembrane, and HAMP domains have been removed,
they are quite useful for investigating mechanisms of signal propagation through the
cytoplasmic domain. Therefore, in vitro CF assembly methods have proven to be a
powerful approach to probe chemotaxis signaling mechanisms in these regions, including
signaling state dependent dynamics (Koshy et al., 2014; Kashefi and Thompson, 2017)
and receptor conformational changes (Vaknin and Berg, 2007; Sferdean et al., 2012).
The ligand-induced expansion model put forth by Sferdean, Thompson and
coworkers is rooted in an observed density dependence of signaling output (Besschetnova
et al., 2008). Besschetnova assembled cytoplasmic fragments (CF) of the aspartate
receptor into arrays at the lowest (4E) and highest (4Q) levels of covalent modification.
Increasing the receptor density—controlled by altering available lipid surface area per
CF—resulted in a cooperative increase in kinase activity and FRET efficiency, which
indicated a decrease in interdimer receptor distances, for CF4E. Moreover, low CF4E
surface concentrations in the presence of CheA and CheW exhibited both decreased
kinase activity and increased methylation activity, consistent with the inverse activity
properties of the native receptor. Sferdean showed that reconstituted intact receptors
retain similar ligand affinities at both low and high receptor densities, indicating
receptors do not dissociate at low densities (Sferdean et al., 2012). From these combined
results, it was proposed, as illustrated in Figure 1.4, that receptors undergo a signaling-
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related conformational change in which the trimers of dimers are expanded in the kinaseoff state, and more compact in the kinase-on state (Sferdean et al., 2012).

Figure 1.4. Proposed ligand-induced expansion model for chemotaxis signaling. This
model is based on observed density-dependent kinase activity and methylation for
vesicle-assembled CF4E, combined with evidence for density-independent ligand affinity
for reconstituted intact receptors (Besschetnova et al., 2008; Sferdean et al., 2012).
Alternatively the observed density-dependent signaling could be a result of
scattered core units when assembled at low densities (with an excess of vesicle surface
area) that gain full activity upon formation of larger array units (eg a hexagon) when
assembled at high densities. Ultimately, it remains unclear whether the density
experiments are an effect of crowding or can be attributed to an increase in array size.

1.3. Objectives
Current views of the assembly mechanism for arrays are based solely on the
variety of complexes observed by ECT in images of reconstituted receptor complexes
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(Figure 1.5). While these images are suggestive of the proposed progression from trimers
of dimers to core complexes to hexagons, methods are needed to directly monitor the
time course of assembly of ternary complexes into hexagonal arrays and to determine
when the system achieves each function.

Figure 1.5. Tomographic evidence of small units lead to proposed model of assembly.
(A) Smaller structures include (1) two linked trimers of dimers and (2) single hexagons
containing six trimers of dimers. Hexagons are linked together in (B, 3) and are presumed
to combine to form a hexagonal array patch (C, 4). Adapted from (Briegel and Jensen,
2017).
To address this, Chapter 3 describes a novel mode of assembling in vitro
chemoreceptor arrays that mimic native structure and function. We show that soluble
cytoplasmic fragments (CF) of the aspartate chemoreceptor fused with N-terminal Histags dimerize upon addition of divalent metals, and form arrays with native architecture,
stoichiometry, and kinase activity. The metal-mediated His-tag dimerization strategy
provides a new approach to stabilize multi-protein assemblies for analysis of protein
mechanisms within their native complexes.
Chapter 4 describes the use of this method to monitor the kinetics of assembly and
gain insight into the mechanism and the minimum functional unit. ECT is best suited to
detect large and highly ordered complexes, and thus cannot be used to detect small and/or
less ordered species and to quantify the distribution of species during assembly of the
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array. Therefore, we turned to size exclusion chromatography (SEC) to probe size
changes over time. Other in vitro assembly methods for CF complexes are incompatible
with SEC; vesicles are significantly larger than the proteins and would therefore mask the
size changes that occur during assembly of the complexes, and the high concentrations of
PEG8000 required for assembly would foul the column. The metal-mediated assembly,
however, was perfectly suited for SEC analysis to track the process of assembly and
probe array formation in parallel with kinase activity. We find that complete binding of
CheA and CheW formation does not immediately yield full kinase activity. This suggests
an alternative to the ligand-induced expansion model: rather than modulating an
expansion/contraction transition of the receptor, high density assembly conditions may
lead to higher activity by causing core units to coalesce into larger complexes.
Lastly, Chapter 5 lays the groundwork to obtain NMR distance constraints for the
receptor trimer of dimers (which is absent in crystal structures of complexes and distorted
in crystal structures of CF alone) and to test whether the trimer expands in the kinase-off
state. We initiated a paramagnetic relaxation enhancement (PRE) based solid-state NMR
approach to obtain long-range (≥ 20 Å) distance constraints across the trimer of dimers
interface. By incorporating a nitroxide spin label with 75% efficiency, we are able to
observe PRE effects in the membrane-proximal region of CF that are consistent with
predictions based on the structural model.
In summary, the work presented here uses a novel His-tag mediated assembly tool
to provide new insights into the mode of chemoreceptor array assembly and the role of
the core functional unit, and lays the groundwork to further interrogate signaling
mechanisms in the context of the native array.
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CHAPTER 2
MATERIALS AND METHODS
2.1. Proteins
2.1.1. Expression Plasmids and Cloning
The E. coli expression strain BL21(DE3) was used to overproduce all proteins
used in this study. TEV-cleavable His-tagged CheA, CheW, and CheY plasmids were
constructed by Aruni P. K. K. Mudiyanselage as previously described (Kashefi and
Thompson, 2017). Expression plasmids for the aspartate chemoreceptor Tar cytoplasmic
fragment (CF), containing residues 257-553 with an N-terminal hexahistidine-tag, encode
glutamine at all four primary methylation sites (pHTCF4Q) or glutamic acid (pHTCF4E)
and were previously constructed (Wu et al., 1996). A CF4E mutant (pCF4E.S487C) was
generated previously (Mudiyanselage et al., 2013) and used in this study for spin labeling
and NMR (see section 2.8.2 and Chapter 5). For protein production, all CF plasmids were
co-transformed into BL21(DE3) with pCF430 (encoding lacIq and tetR).
To generate a TEV-protease (tobacco etch virus)-cleavable His-tagged version of
pHTCF4Q, the recognition and cleavage sequence for TEV-protease (ENLYFQG) was
inserted directly following the N-terminal His6-tag of pHTCF4Q using site-directed
mutagenesis

and

polymerase

chain

reaction

(PCR).

Forward

(5’-

GAAAACCTGTATTTTCAGGGCGGA TCCCCTATGCAACG-3’) and reverse (5’GCCCTGAAAATACAGGTTTTCGTGATGGTGATGGTGATG-3’)

overlapping

primers were designed to include the TEV-protease recognition sequence and were
purchased from Eurofins Genomics. The PCR reaction was done in a thermocycler (Bio-

17

Rad MJ Mini), and reagents, including Phusion DNA polymerase, dNTPs, and DpnI were
purchased from New England Biolabs. The PCR product (pTEVCF4Q, ampR) was
subjected to DpnI digestion and transformed into DH5αF’ for plasmid purification.
Following sequence verification (Genewiz), pTEVCF4Q was co-transformed with
pCF430 (encoding lacIq and tetR) into BL21(DE3) for protein expression.

2.1.2. Tar cytoplasmic fragment (CF)
BL21(DE3) E. coli cells expressing H6CF (pHTCF4Q, ampR) or H6TEV-CF
(pTEVCF4Q, ampR) co-transformed with pCF430 (tetR) were grown in Luria-Bertani
(LB) broth with ampicillin (100 µg/mL) and tetracycline (10 µg/mL) at 37°C until the
optical density at 600 nm reached approximately 0.6. The temperature was decreased to
15°C for induction with 1 mM IPTG for 16–18 h. Cells were pelleted, resuspended in
lysis buffer [75 mM KxHxPO4 (pH 7.5), 500 mM NaCl, 5 mM imidazole, and 1 mM
EDTA], and lysed with a microfluidizer at 16K psi. PMSF (1 mM) was added every hour
following cell lysis to limit proteolysis. Cell debris was separated by centrifugation and
the supernatant applied to a HisTrap FF Ni2+-NTA affinity column (GE Healthcare)
equilibrated with 10 column volumes of 75 mM KxHxPO4 (pH 7.5), 500 mM NaCl, and 5
mM imidazole. The column was washed with 5 column volumes of 75 mM KxHxPO4 (pH
7.5), 500 mM NaCl, and 50 mM imidazole, before elution with 75 mM KxHxPO4 (pH
7.5), 500 mM NaCl, and 500 mM imidazole. Eluted protein was verified by SDS-PAGE
and fractions were pooled prior to treatment with 5 mM EDTA to chelate any Ni2+
stripped from the column, followed by dialysis against 75 mM KxHxPO4 (pH 7.5) 75 mM
KCl with 7 kDa molecular weight cutoff SnakeSkin tubing (Thermo Scientific) to remove
EDTA and imidazole and to exchange high NaCl concentrations for low KCl
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concentrations. Typically half of the purified H6TEV-CF was subjected to His-tag
removal by TEV-protease cleavage.
For isotopic labeling, BL21(DE3) cells harboring pCF4E.S487C (ampR) and
pCF430 (tetR) were grown in M9 minimal media using natural abundance glucose and
(15NH4)2SO4 as the carbon and nitrogen sources. Starter cultures were prepared from
single colonies grown on LB amp/tet plates that were inoculated into ~5 mL LB broth
supplemented with ampicillin (100 µg/mL) and tetracycline (10 µg/mL), and grown until
~0.6 OD600 at 37°C. This was used to inoculate 1 L minimal media, which was typically
grown overnight at 30°C with 200 rpm shaking until OD600 ~ 0.7–0.9. Protein production
was induced with 1 mM IPTG for 5 h at 25°C. Cells were harvested and purification as
described above, with the exception that 2 mM TCEP was included in all buffers except
the final dialysis buffer for protein storage.

2.1.3. TEV-cleavable His-tagged CheA, CheW, and CheY
Plasmids encoding TEV-cleavable His-tagged CheA (pTEVcheA, kanR), CheW
(pTEVcheW, kanR), and CheY (pTEVcheY, kanR) were expressed in BL21(DE3) and
grown at 37°C in LB broth supplemented with 50 µg/mL kanamycin. At an optical
density at 600 nm of ~0.7–0.9, 1 mM IPTG was added to induce expression for 3 h
before the cells were harvested and purified with HisTrap affinity chromatography as
described for CF (section 2.1.2). A different buffer system for CheA, CheW, and CheY
purification was used: lysis buffer [75 mM Tris-HCl (pH 7.4), 100 mM KCl, and 1 mM
EDTA], equilibration buffer [75 mM Tris-HCl (pH 7.4), and 100 mM KCl], wash buffer
[75 mM Tris-HCl (pH 7.4), 100 mM KCl, and10 mM imidazole], and elution buffer [75
mM Tris-HCl (pH 7.4), 100 mM KCl, and 250 mM imidazole]. Following elution,
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fractions containing protein were verified by SDS-PAGE, pooled and treated with 5 mM
EDTA, then dialyzed as for CF into 75 mM Tris-HCl (pH 7.4) and 100 mM KCl prior to
His-tag removal.

2.1.4. TEV-protease
The plasmid pRK793 (ampR) encoding N-terminally His-tagged TEV-protease (a
gift from D. Waugh, Addgene plasmid 8827) (Kapust et al., 2001) was expressed in
BL21(DE3)-RIL (ampR). Cells were grown at 37°C in LB broth containing 150 µg/mL
ampicillin and 50 µg/mL chloramphenicol. When an optical density of 0.6 was reached,
protein production was induced at 30°C with 1 mM IPTG for 4 h. The protein
purification protocol and buffer system for CheA, CheW, and CheY was also used here
(see section 2.1.3).

2.1.5. His-tag cleavage
Following purification, CheA, CheW, CheY, and H6TEV-CF were incubated with
TEV-protease at a 50:1 His-tagged protein:TEV-protease molar ratio, and the mixture
was shaken at 4°C overnight and then 25°C for 3 h. Complete cleavage was confirmed by
a gel shift observed by SDS-PAGE. Cleaved proteins were separated from TEV-Protease
by passage through the equilibrated HisTrap column, collected, and concentrated with 10
kDa centrifugal concentrators (Amicon). Protein concentrations were measured with a
BCA assay (Thermo Scientific), and proteins were frozen in liquid nitrogen and stored at
-80°C.
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2.2. Lipid Vesicles
A mixture of DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) and the nickelchelating

lipid

DOGS-NTA-Ni2+

(1,2-dioleoyl-sn-glycero-3-{[N-(5-amino-1-

carboxypentyl)-iminodiacetic acid]succinyl}) (Avanti Polar Lipids) were combined in
chloroform at a 1.5:1 DOPC:DOGS-NTA-Ni2+ molar ratio. Lipids were dried into a thin
film with a stream of N2 gas and left under vacuum for 1 h before being rehydrated with
1× PKB [phosphate kinase buffer: 50 mM KxHxPO4 (pH 7.5), 50 mM KCl, and 5 mM
MgCl2] and vortexed extensively (30 s vortex, 5 min rest, repeated three times) to form
multilamellar vesicles, followed by five cycles of 3-minute freezing/thawing.
Freeze/thaw cycles were accomplished as follows: the lipids were dipped in liquid
nitrogen for 20 s to freeze, left on the bench for 3 min, and then held for 3 min in a 37°C
water bath. Extrusion was then performed with an extrusion apparatus (Avanti Polar
Lipids) using a 100 nm diameter pore size polycarbonate membrane. High-concentration
stocks at 3 mM total lipid (1.8 mM DOPC and 1.2 mM DOGS-NTA-Ni2+) were prepared
and a final [lipid]total of 725 µM was used for assembly. The lipid concentrations were
optimized in parallel with CheA and CheW concentrations to maximize kinase activity
under conditions under which the available vesicle surface area could accommodate all
CF as hexagonal arrays (See Appendix).

2.3. Complex Assembly
Preparation of ternary complexes was performed as previously described for
vesicles (Shrout et al., 2003) and PEG (Fowler et al., 2010) with some modifications.
Briefly, vesicle samples were prepared by combining the following (in order): autoclaved
water, 1 mM PMSF dissolved in 100% ethanol, phosphate kinase buffer (PKB) from 5x
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stock, 12 µM CheA, 24 µM CheW, 30 µM CF (H6CF, H6TEV-CF, or ΔH6CF), 725 µM
vesicles. PEG-assembled samples were made by combining the following (in order):
autoclaved water, 1 mM PMSF, PKB, 12 µM CheA, 20 µM CheW, 50 µM CF (H6CF,
H6TEV-CF, or ΔH6CF), 7.5% w/v PEG8000 (from a 40% w/v stock), 4% w/v D-trehalose
(from a 40% w/v stock). Metal-assembled samples were prepared under protein and
buffer conditions equivalent to those optimized for vesicle-assembly, except that vesicles
were replaced with metal salts (NiCl2•6H2O, ZnCl2 anhydrous, CuCl2•2H2O,
MnCl2•4H2O, and CoCl2•6H2O, all obtained from Sigma-Aldrich) prepared at ~1 mM in
autoclaved Milli-Q H2O. Metal stock concentrations were verified before use (see section
2.5). All metal-mediated assembly experiments outside of the metal titration (see section
3.2.1) used metal concentration conditions that produced the largest quantity (based on
sedimentation) of maximally active complexes (NiCl2 was 180 µM, ZnCl2 was 300 µM,
and CoCl2 was 360 µM). For the mixed NiCl2 and PEG-mediated CF4E assembly (see
section 3.2.7), 180 µM NiCl2, 7.5% w/v PEG, and 4% w/v D-trehalose were used; protein
concentrations matched those of PEG-mediated assembly).
Once combined, samples were incubated in a 25°C water bath for 4 h or overnight
before use. For kinetic experiments, biochemical assays or SEC-MALS were performed
at time points immediately following addition of all complex components.

2.4. Biochemical Assays
2.4.1. CheA kinase activity
Kinase activity was measured using an enzyme-coupled ATPase assay that
couples NADH oxidation to consumption of ATP (Nørby, 1988; Shrout et al., 2003).
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Briefly, activity measurements were conducted immediately following a 100-fold dilution
of

assembled

complexes

into

PKB

containing

55

µM

CheY,

2.2

mM

phosphoenolpyruvate, 4 mM ATP, 250 µM NADH, and 20 units of PK/LDH enzyme
(Sigma-Aldrich). New CheY preparations were tested at both 55 µM (1X) and 110 µM
(2X) to confirm the rates were unchanged and excess CheY was available so that
phosphorylation of CheA was rate limiting. The background activity of CheY under
identical conditions in the absence of the complex was subtracted before calculation of
kinase activity. The kinase activity (inverse seconds) was determined from the linear
change in absorbance at 340 nm [d[ATP]/dt = –6220(dA340/dt)] over 1.5 min. Total
activity is based on the full amount of CheA in the sample (12 µM), which is divided by
the amount of CheA in the complex (quantified by sedimentation, as described in 2.4.2)
to compute the specific activity of CheA in complexes with CF.

2.4.2. Binding assay
The amount of bound protein was determined with a sedimentation assay carried
out at 25°C in a benchtop ultracentrifuge (Beckman TLX, TLA 120.2 rotor, 125,000g, 30
minutes). Typically, a 35 µL aliquot of sample (in either assembled ternary complexes or
individual proteins) was centrifuged. Following sedimentation, the supernatant was
carefully removed and placed into a clean Eppendorf tube to minimize contamination of
free protein in the pellet containing the bound fraction of proteins. The pellets were
slowly resuspended to the original volume in autoclaved Milli-Q H2O and vortexed to
homogenize resuspension. Aliquots of Total (free plus bound protein, before
sedimentation), Supernatant (free protein), and Pellet (bound protein) were run on SDSPAGE (12.5% acrylamide) and stained with Gel-code Blue (Pierce Chem. Co.). Gels
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were imaged by densitometry with a Gel Doc EZ Imager (Bio-Rad) and the integrated
intensities were analyzed with ImageJ software.(Schneider et al., 2012) The bound
concentrations were computed as (IPellet/ITotal) x [Protein]Total for each protein to be
quantified. For the excess CheA and CheW conditions used in this study, quantification
of bound protein by the pellet was more reproducible than (ITotal – ISupernatant). [For future
studies, we suggest making the Pellet gel sample from the entire resuspended pellet. This
might further increase reproducibility, by making it unnecessary to achieve a complete
and homogeneous resuspension of the pellet.] Gels included two additional lanes of the
Total sample diluted 6x and 12x such that a calibration curve from three intensities for
known concentrations could be calculated. The y-intercept was then subtracted from each
integrated intensity to correct for the gel background intensity and more accurately
estimate the fraction of protein bound in a complex.

2.4.3. Methylation assay
Methylation assays were carried out on various complexes following overnight
assembly. Vesicle- and Ni(II)-mediated assemblies were prepared normally (section 2.3),
while NiCl2 + PEG-mediated assemblies contained: 180 µM NiCl2, 7.5% PEG8000, 4%
D-trehalose,

50 µM CF, 12 µM CheA, and 20 µM CheW. Methylation was initiated upon

the addition of 6 µM CheR (prepared previously by Guoyong Li) and 10 µM S-adenosylL-methionine

(SAM, Sigma Aldrich). Aliquots were removed after 0.1 and 4 h, quenched

by the addition of gel-loading buffer, and analyzed by SDS-PAGE. Quantification was
done with ImageJ (Schneider et al., 2012).
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2.5. Inductively Coupled Plasma Optical Emission Spectroscopy
Metal concentrations of the ~1 mM aqueous metal stocks (NiCl2, ZnCl2, CuCl2,
MnCl2, CoCl2) and the amounts of metal bound to H6CF (alone or in complex) were
measured using a PerkinElmer Optima DV4300 inductively coupled plasma opticalemission spectroscopy (ICP-OES) instrument. Metal standards (TraceCERT by SigmaAldrich) were used to produce a calibration curve for each metal at 0.1, 0.2, 0.75, 1, 2,
and 10 ppm. Metal stocks were diluted 100-fold and protein-metal samples were diluted
10-fold into MilliQ water that was also used to blank the instrument. Protein samples
were prepared by overnight incubation of 30 µM H6CF (alone or with 12 µM CheA and
24 µM CheW) with the metals at the optimal concentrations that produced active
complexes (180 µM NiCl2, 300 µM ZnCl2, or 360 µM CoCl2) in a 25°C water bath.
Aliquots of these samples were then subjected to ultracentrifugation (60k rpm for 30
minutes at 25°C) to separate large metal-protein complexes from unbound protein and
metal in the supernatant. Bound protein and metals in the pellet were carefully
resuspended to the initial volume in MilliQ water. The entire resuspended pellet was used
for ICP-OES analysis so that any chunks of protein pellet were still part of the sample
measured.

2.6. Size Exclusion Chromatography with Multi-Angle Light Scattering
Size exclusion chromatography and multi-angle light scattering (SEC-MALS)
was used to monitor metal-mediated complex formation. The SEC is coupled to an 18angle static light scattering detector (DAWN HELEOS-II), a dynamic light scattering
detector (WyattQELS), and a differential refractometer (Optilab T-rEX, Wyatt
Technology). Proteins were injected onto a TSKgel G2000SWXL column maintained at
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4°C and pre-equilibrated overnight with PKB buffer (pH 7.0) kept on ice. Typical
injections were 75 µL of 0.5-3 mg/mL protein. Data was collected every second for 30
minutes at a flow rate of 0.5 mL/min. Protein elution was monitored at A280 and A214, in
addition to static and dynamic light scattering. The accompanying ASTRA VI software
was used to determine molar mass, peak polydispersity, and UV peak areas for all
individual peaks and the entire elution to determine % loss in the pre-column 0.22 µm
filter.

2.7. Electron Cryo-Tomography (ECT)
All ECT presented in this study was done by our collaborators Ariane Briegel and
Wen Yang at the NeCEN Facility run by the University of Leiden. Samples were
prepared by mixing protein assemblies (see section 2.3) with a bovine serum albumintreated 10 nm colloidal gold solution (Cell Microscopy Core, Utrecht University, Utrecht,
The Netherlands). After brief vortexing, 3 µL mixtures were applied to freshly plasmacleaned R2/2 copper Quantifoil grids (Quantifoil Micro Tools). Blotting and plunge
freezing in ethane were done in approximately 1 second with a Leica EMGP (Leica
microsystems, Wetzlar, Germany), set at 20°C and 95% humidity. Grids were stored in
liquid nitrogen until imaging. Data was collected on a Titan Krios transmission electron
microscope from Thermo Fisher Scientific (formerly FEI; Hillsboro, Oregon) with a field
emission gun operating at 300 kV. The microscope was equipped with a Gatan
(Pleasanton, CA) image filter and a Gatan K2 Summit direct electron detector. Data
acquisition was done using Tomography 4.0 (Thermo Fisher Scientific) in batch mode.
Tilt series for PEG and Ni(II)-assembled H6CF ternary complexes were collected at a
nominal magnification of 42,000x and 33,000x, respectively. A discontinuous tilt scheme
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was used for imaging, taking images from 0° to −60° followed by 0° to +60° with a 2°
tilting increment. The cumulative dosage for each tilt series was 80 e/A2. Defocus was set
to -8 µm. The tilt series for Ni(II)-assembled H6CF (without CheA or CheW) and PEGassembled ΔΗ6CF complexes were collected using the same tilt scheme but at a defocus
of -300 nm with volta phase plate (VPP) (Thermo Fisher Scientific). The VPP was heated
to 225°C and activated for 80s before each tilt series aiming to generate an approximate
phase shift of 90° (Danev et al., 2014). An extra 5s conditioning time was applied
between each tilt image. All images were acquired using the low-dose routine integrated
in the Tomography software. Drift correction and tilt series alignment were performed
with software package IMOD (Kremer et al., 1996; Mastronarde, 1997). Tomograms
were reconstructed using both weighted back-projection (WBP) and 9 iterations of
simultaneous iterative reconstruction (SIRT). PEET was used for subvolume averaging
(Nicastro et al., 2006). Visualization and image analysis were carried out with Image J
and Chimera (Pettersen et al., 2004; Schneider et al., 2012).

2.8. Solid-State Nuclear Magnetic Resonance
2.8.1. Paramagnetic spin labeling
The nitroxide paramagnetic spin label MTSL [(1-oxyl-2,2,5,5-tetramethyl-Δ3pyrroline-3-methyl)methanethiosulfonate] was purchased from Toronto Research
Chemicals, immediately solubilized in 100% acetonitrile to a stock concentration of 100
mM, and stored at –20°C wrapped in parafilm and aluminum foil to prevent evaporation
and light damage.
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To prepare the CF4E.S487C for labeling, dimers were first reduced with a 5 mM
TCEP treatment for 30 min in a 25°C water bath. Approximately 2 mL protein was
injected per 5 mL HisTrap desalt column (GE Healthcare) equilibrated with 75 mM
KxHxPO4 (pH 7.4) and 50 mM KCl using a 5 mL syringe. For larger protein volumes,
multiple 5 mL desalt columns were used in series. Initially, the flow through was
collected in 0.5 mL fractions and the protein was eluted at 2.0–4.5mL (as monitored by
A280 and SDS-PAGE). This elution profile was highly reproducible for a 2 mL injection
volume into a single 5 mL column, and generally imparted a 1.3-fold dilution. It took at
least 1.5 hours following the TCEP removal desalt column to identifying the proteincontaining fractions with SDS-PAGE so this step was eliminated once the reproducibility
of the desalt elution profile was confirmed. A number of spin labeling protocols were
tested, including binding the protein to a Ni2+-affinity column and flowing an 800 µM
MTSL solution (25 mL of 75 mM KxHxPO4 (pH 7.4), 50 mM KCl and 200 µL of 100
mM acetonitrile-dissolved MTSL) through the column in a loop overnight, and
incubation of 200–800 µM CF with 20-fold excess MTSL in 75 mM KxHxPO4 (pH 7.4)
and 50 mM KCl for times and temperatures ranging from 4–72 hours and 4–25°C. We
found that the least dimers formed when the protein was eluted from the desalt column
for TCEP removal directly into a tube containing a 20-fold molar excess of MTSL to
minimize dimer formation. This solution was then left gently stirring overnight at 4°C.
MTSL was subsequently removed with another desalt column, and the eluted protein
concentration was measured by BCA assay, since MTSL absorbs light at 280 nm (a 1
mM solution of MTSL in water is ~0.7 at 280 nm, but does not react with the BCA assay
reagents).
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2.8.2. NMR Sample preparation
Each NMR sample was assembled as 14 mL of the vesicle-mediated complex and
incubated at 25°C overnight. The kinase activity and sedimentation were measured prior
to packing the NMR rotor to confirm successful assembly. Total kinase activities were
typically 5–7 s–1 and protein binding stoichiometries were ~ 6 CF:1 CheA:2 CheW. The
samples were pelleted by ultracentrifugation for 2.5 h at 25°C with 24,000 rpm in a
Beckman Ti70 rotor. The pellet was packed into a 50 µL restricted volume 4 mm Bruker
rotor by first transferring the pellet to a 200 µL flame-sealed pipette tip with a spatula.
The tip was placed into a test tube, stabilized with Kimwipes, and gently centrifuged (a 5
second pulse up to ~6k rpm) to move the pellet to the tip base. The flame seal was
removed with a razor and inserted into the rotor and centrifuged as before. The top plastic
insert and cap were then used to estimate the level to pack the rotor, and subsequently
used to seal it tightly. Approximately 45 mg of assembled complex were packed into
each rotor. The mass of CF in each sample was calculated as (total volume of complex) ×	
 
(CF concentration) ×	
  (packed sample weight)/(total pellet weight), resulting in ~286
nmol of labeled CF for both MTSL-labeled and non-labeled U-15N-CF4E.S487C NMR
samples.

2.8.3. Spectroscopy and data analysis
All NMR experiments were done on a 14.1 T Bruker Avance III spectrometer (1H
= 600 MHz,

13

C = 150 MHz,

15

N = 60 MHz) in a 4 mm E-free HCN probe. Sample

temperature was estimated by a calibration of the chemical shift changes of TmDOTP
(Zuo et al., 1998) dissolved in DMPC vesicles at ionic strengths similar to protein
samples; heating due to decoupling and MAS was counterbalanced with VT gas flow
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cooling, for an effective sample temperature of ~10–15°C. A one-dimensional (1D)
sequence for cross-polarization/magic angle spinning (CP/MAS) was used with 11.1 kHz
MAS, a contact time of 1.5 ms, and a recycle delay of 1 s. The 90° pulses were 2.8 µs and
5.6 µs for 1H and

15

N, respectively, with SPINAL-64 1H decoupling at 92.5 kHz. Each

1D spectrum contained the combined FIDs for 9600 scans (collected in 2400 scan
blocks), for a total experiment time of ~3 hr.
Topspin 3.2 was used for all data processing. Chemical shifts were referenced to
adamantane at 40.5 ppm (relative to DSS at 0 ppm), and no line broadening was applied.
Spectra for with or without spin label were overlaid in the Topspin multiple display
feature without additional scaling; the difference spectrum was likewise created using the
Topspin, but the intensity was scaled up 2-fold for the final comparison in Figure 5.6.
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CHAPTER 3
METAL-MEDIATED HIS-TAG DIMERIZATION FOR ASSEMBLY OF
CHEMORECEPTOR ARRAYS
This chapter describes the use of divalent metals to initiate chemoreceptor His-tag
dimerization and drive assembly of native-like arrays in vitro. Most of this chapter was
published in the article “His-tag-mediated dimerization of chemoreceptors leads to
assembly of functional nanoarrays” in Biochemistry (Haglin et al., 2017).

3.1. Introduction
Many fundamental biological processes are carried out by multi-protein
complexes (Alberts, 1998; Marsh and Teichmann, 2015). To fully understand how these
processes occur within the cell, methods are needed both for monitoring such processes
in vivo and for isolation and/or reassembly of such complexes for in vitro structure–
function analysis. Isolation and reassembly of complexes often requires modifications or
deletions of portions of the protein components: for instance, deletion of transmembrane
domains of membrane proteins may be needed to prepare homogeneous complexes for
structural or biophysical studies. Typically, such truncations also delete stabilizing
interactions, and it becomes difficult to reassemble complexes with native-like
architecture and activity. We have developed a novel strategy for the stabilization of
assemblies with native structure and activity for in vitro mechanistic studies.
Bacterial chemotaxis receptors are an ideal system for understanding the
molecular details of signal transduction by membrane proteins and their complexes.
Chemotaxis receptors are dimeric transmembrane proteins anchored in the inner–
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membrane in large patches at the poles of the cell, which are responsible for sensing and
responding to environmental stimuli. Upon ligand binding to the receptor periplasmic
domain, a signal is transmitted down the ~300 Å length of the receptor to control the
autophosphorylation activity of an associated histidine kinase, CheA, which plays a
central role in the signal transduction pathway. In addition to forming a complex with
CheA and an adapter protein CheW, receptors form large clusters (a membrane surface
area of 53000 nm2 for E. coli) (Maddock and Shapiro, 1993; Zhang et al., 2007; Briegel
et al., 2009) that enable extraordinary levels of cooperativity and sensitivity (Sourjik and
Berg, 2002, 2004). The native system is built of trimers of receptor dimers that each form
one vertex of a hexagon within the membrane and are stabilized at the membrane-distal
tip of the receptor by hexagonal rings of alternating CheA and CheW (Briegel et al.,
2012; Liu et al., 2012; Cassidy et al., 2015). It is challenging to prepare homogeneous
samples of functional chemoreceptor complexes in vitro for structure–function analysis.
Complexes of the intact membrane-bound receptor with CheA and CheW are not
homogeneous, in part due to the inability to control orientation of the receptor within
membrane vesicles (Sferdean et al., 2012; Briegel et al., 2014a) or nanodiscs (Boldog et
al., 2006). In principle, the membrane orientation issue can be addressed by using a
cytoplasmic fragment of the receptor, but this truncated construct does not form
functional complexes with CheA and/or CheW in solution. Presumably, this is because
the missing transmembrane and periplasmic domains are needed to provide protein–
protein interactions that stabilize the receptor dimer and geometrical alignment within the
membrane that promotes assembly of the array.
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In an elegant combination of membrane mimetics and nano-scale assembly tools,
Weis and coworkers developed templating vesicles that promote the assembly of
membrane-associated multi-protein complexes from soluble component proteins. This
technology harnesses the high affinity interaction between histidine imidazole groups and
the Ni(II)-NTA functional group originally developed for immobilized metal affinity
chromatography protein purification (Hochuli et al., 1987). The N-terminally His-tagged
cytoplasmic fragment (CF) of the aspartate chemoreceptor binds to vesicles containing
lipids with nickel-chelating headgroups (DOGS-NTA), which enables binding of CheA
and CheW into ternary complexes with kinase and methylation activity that mimic native
signaling states (Shrout et al., 2003; Besschetnova et al., 2008). Molecular crowding
agents such as PEG8000 provide an alternate means of driving assembly of functional
complexes, with no requirement for membrane vesicles (Fowler et al., 2010). Both
assembly methods result in extended hexagonal arrays with native-like architecture
(Briegel et al., 2014a), and PEG-mediated assembly forms sandwich lattices remarkably
similar to cytoplasmic chemoreceptor arrays seen in some bacterial species (Briegel et al.,
2014a, 2016)
Here we report a novel method for assembling functional arrays in vitro. We show
that adding divalent metal salts to ternary mixtures of His-tagged CF, CheA, and CheW
promotes receptor dimerization and assembly into active complexes with native
stoichiometry and architecture. This dimerization strategy may prove to be valuable for
assembly of other complex systems, particularly given the widespread use of
polyhistidine-tags as a convenient and effective affinity tag capable of facilitating a
variety of applications.
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Cornelissen, van Hest, and coworkers discovered that metal-ion-induced
interactions between His tags could be used to stabilize a capsid assembly that is
otherwise unstable in the absence of a high negative charge from either encapsulated
RNA or low pH. By the simple addition of divalent metals to the His-tagged cowpea
chloric mottle virus capsid protein, capsid structures with native particle size form at
neutral pH and can be used to encapsulate other proteins or drugs (Minten et al., 2011;
Van Eldijk et al., 2016). Their model suggests the metal promotes His-tag-to-His-tag
interactions that stabilize the large oligomeric capsid structure. This chapter describes a
similar phenomenon that we demonstrate is a metal-mediated dimerization. His-tag
mediated dimerization provides a new approach to stabilize multi-protein assemblies for
analysis of protein mechanisms within their native complexes.

3.2. Results and Discussion
3.2.1. Divalent metals restore chemoreceptor ternary complex formation and
function
Assembling aspartate chemoreceptor cytoplasmic fragments (CF) into functional
arrays with CheA and CheW has thus far been accomplished with templating vesicles
(Shrout et al., 2003), lipid monolayers (Cassidy et al., 2015), and with molecular
crowding agents (Fowler et al., 2010). Under conditions similar to those used to form
functional complexes with templating vesicles, we have discovered that some divalent
metals are sufficient to restore function, with no requirement for vesicles. A series of
metal titrations reveal the conditions needed to restore both kinase activity of CheA
(measured with an enzyme-coupled ATPase assay, using the native phosphoryl acceptor
protein CheY) and ternary complex formation (measured with sedimentation assays).
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Five divalent metal chlorides were tested (NiCl2, ZnCl2, CoCl2, CuCl2, and MnCl2) at
concentrations ranging from 0 to 540 µM, while keeping protein concentrations constant
at levels that promote maximal incorporation of CF into functional complexes (30 µM CF
plus excess CheA (12 µM) and CheW (24 µM)). As shown in Figure 3.1, NiCl2 promotes
active complex formation at the lowest concentrations, with maximum kinase activity
reached at 180 µM NiCl2. The optimal ZnCl2 concentration for kinase activity is 300 µM,
and the total kinase activity is 90% of the highest observed for NiCl2. While CoCl2 also
produced active complexes in this titration series, the highest kinase activity (reached at
360 µM CoCl2) is only 50% of the optimal NiCl2 sample. Thus the relative efficiency of
these metals for promoting assembly of functional complexes is NiCl2 > ZnCl2 > CoCl2.
Interestingly, the sedimentation trends for CF, CheA, and CheW with each metal titration
track mostly with the respective onset of activity (Figure 3.2). For example, NiCl2assembled complexes show both activity and sedimentation beginning at low NiCl2
concentrations, and ZnCl2-assembled complexes show nearly zero sedimentation until
180 µM ZnCl2, where activity is first observed. Furthermore, maximal sedimentation of
CF, CheA, and CheW is reached for most cases under conditions that give maximal
activity, and the CoCl2 titration reaches activity and sedimentation of only 50% of the
optimal NiCl2 sample. Thus three divalent metals restore the ability of the chemotaxis
receptor CF to assemble with CheA and CheW into sedimentable complexes that activate
the kinase CheA.
Interestingly, NiCl2 concentrations higher than 180 µM are clearly detrimental to
kinase activity, and sedimentation of CF increases an additional 15%, while CheA and
CheW sedimentation remain constant (Figure 3.2). In contrast, ZnCl2 and CoCl2 cause
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only a modest decrease in activity at high concentrations (and no significant additional
sedimentation).
Neither CuCl2 nor MnCl2 restored formation of active complexes. Kinase activity
throughout the titration is similar to that of the proteins with no metal (< 1s-1).
Furthermore, all samples with CuCl2 and MnCl2 also had very low protein sedimentation
of <15%, again similar to levels for the no-metal control, with the exception of CuCl2 and
CheA. At high [CuCl2], nearly all of CheA sedimented (data not shown). Since there is
no appreciable kinase activity or sedimentation of CheW and H6CF, we can conclude that
CuCl2 is most likely causing aggregation of CheA.
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Figure 3.1. Three divalent metals promote kinase. All experiments use excess CheA and
CheW, under conditions optimized for maximal incorporation of CF into complexes with
maximal kinase activity (30 µM H6CF, 12 µM CheA, 24 µM CheW). Additions of NiCl2
(filled circles), ZnCl2 (filled triangles), or CoCl2 (filled diamonds) each promote kinase
activity, with NiCl2 promoting the highest activity, followed by ZnCl2 and then CoCl2.
Both CuCl2 (open circles) and MnCl2 (open triangles) do not promote activity: activity
comparable to the no-metal control is observed at all metal concentrations. As a positive
control, PEG-mediated samples were run in parallel, with typical total kinase activities
~11 s-1. Arrows denote maximally active conditions used for further studies, including
metal:protein stoichiometry measurements listed in Table 3.1. Activities are averages of
four to eight replicates measured on two or three days; error bars indicate ± one standard
deviation. For this plot, measurements on each day were averaged, and the averages for
all days were then combined, with propagation of the errors. Reprinted (adapted) with
permission from (Haglin et al., 2017). Copyright 2017 American Chemical Society.
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Figure 3.2. Divalent metals that promote kinase activity also lead to protein
sedimentation. Quantification of H6CF, CheA, and CheW sedimentation for (A) NiCl2,
(B) ZnCl2, and (C) CoCl2 titration samples shown in Figure 3.1. All samples contain 30
µM H6CF, 12 µM CheA, and 24 µM CheW, but sedimentation is typically less than
100%, particularly for CheA and CheW which are added in excess to drive assembly.
Approximate stoichiometries of the functional complexes were estimated used averages
of the sedimented concentrations for all sample conditions with maximal activity (gray
shaded region): 6:1.3:2.9 for Ni(II)-mediated assembly, 6:1.2:2.7 for Zn(II)-mediated
assembly, and 6:0.9:2.7 for Co(II)-mediated assembly. Reprinted (adapted) with
permission from (Haglin et al., 2017). Copyright 2017 American Chemical Society.
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3.2.2. Stoichiometry of metal bound to receptor
Measurements of bound metals indicate that the active complexes have
metal:protein stoichiometries close to 1:1 (Ni(II) and Co(II)) and 3:1 (Zn(II)). The metal
ion concentrations bound to CF were determined using inductively coupled plasma
optimal-emission spectroscopy (ICP-OES), in samples of active complexes (prepared
with CheA and CheW) as well as CF alone. Metals producing active complexes lead to
sedimentation of both CF alone and CF with CheA and CheW (with the exception of
CoCl2 + CF alone, which does not sediment). Samples were prepared with each metal at
the optimal concentration based on the activity data (Figure 3.1, arrows) and incubated
for long assembly times that maximize kinase activity (greater than 4 h). The bound
protein (CF alone or in complex with CheA and CheW) and metal were separated from
free protein and metal by ultracentrifugation. Resuspended pellets were then analyzed for
metal content by ICP-OES, and protein content by SDS-PAGE (via comparison to a CF
standard measured with a BCA assay). Unfortunately we were unable to implement
sulfur quantification by ICP-OES, which would have enabled measurement of a more
accurate metal:protein ratio as the number of sulfur atoms per CF is known. As listed in
Table 3.1, CF alone and CF in complex have nearly identical stoichiometries for Ni(II)
and Co(II), which suggests that metals bind similarly to CF in both cases. Moreover, the
calculated stoichiometries are both close to one metal ion per CF monomer. In contrast,
Zn(II) exhibited both a higher and a more variable stoichiometry of 3.9 Zn(II) per CF
alone and 3.1 per CF in complexes. Thus, for all three metals, we can conclude that a
large excess (6–12 equiv) is necessary to drive assembly to maximally active CF ternary
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complexes, but only a fraction of metal is directly involved in the assembly. All further
studies were done on Ni(II)-assembled samples at 180 µM NiCl2.
Table 3.1. Stoichiometry of metal binding to CF measured by ICP-OES.a
Metal addedb

Metal bound to CF
alonec

Metal bound to CF in
complexd

Ni(II)

1.2 ± 0.04

1.1 ± 0.05

Zn(II)

3.8 ± 0.16

3.1 ± 0.12

Co(II)

NDe

1.1 ± 0.15

a

Data are averages ± one standard deviation for the number of metal ions bound per CF
monomer from 10 independent ICP-OES measurements of each metal.
b
Metal added at concentrations found to give maximally active complexes (Figure 3.1,
arrows).
c
30 µM CF in assembly.
d
30 µM CF, 12 µM CheA, and 24 µM CheW in assembly.
e
CoCl2 with CF alone does not sediment, and thus, metal content could not be measured.
3.2.3. Receptor His-tag is essential for metal-mediated assembly
We hypothesized that the His-tag could be involved in the divalent metalmediated assembly of functional chemoreceptor complexes, perhaps via stabilization of
CF dimers or oligomers. To test this, we engineered a variant of the CF construct
(henceforth called H6CF for the sake of clarity) by inserting the recognition and cleavage
sequence for TEV-protease after the His-tag (H6TEV-CF). TEV-protease cleavage of
H6TEV-CF yields ΔH6CF, with the native CF sequence plus a single glycine at the Nterminus. For each version of CF (H6CF and H6TEV-CF with His-tags, and ΔH6CF with
no His tag, as shown in Figure 3.3A) we tested the assembly of ternary complexes with
CheA and CheW by three in vitro methods (vesicles, PEG, and Ni(II)) and measured both
the kinase activity and protein stoichiometry of sedimented complexes.
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The three proteins together in buffer with no vesicles, PEG, or divalent metal
show low kinase activity (Figure 3.3B, None) and <15% sedimentation (Figure 3.2). We
had previously observed variable levels of kinase activity for H6CF, CheA, and CheW
assembled in the absence of vesicles, PEG, or added metals, and realized H6CF may
contain variable amounts of Ni(II), stripped from the NTA-affinity column during
purification (Sprules et al., 1998). We incorporated a 5 mM EDTA treatment step into all
purifications, following elution of protein from the column, and this EDTA is removed in
the subsequent dialysis step. Thus the low level of activity and sedimentation observed in
the absence of vesicles, PEG, or metal (Figure 3.3B, None) is not due to adventitious
Ni(II), but presumably reflects the low stability of these complexes formed with the
truncated CF.
As shown in Figure 3.3B, both H6CF and H6TEV-CF complexes are functional
with all assembly methods, indicating that the TEV insertion does not interfere with
assembly of functional CF complexes. As anticipated, removing the His-tag results in no
kinase activity and background levels of protein binding for both vesicle and Ni(II)
assembly methods, demonstrating that the His-tag is required for metal-mediated
assembly.
The native stoichiometry of chemoreceptor arrays is thought to be 6:1:2
receptor:CheA:CheW (Liu et al., 2012; Cassidy et al., 2015). As shown in Figure 3.3C,
all active complexes of the different constructs assembled with vesicles, PEG, or Ni(II)
display near-native stoichiometries. The variation in CheW (ranging from 2.1 to 3.0) may
be due to weak staining of CheW resulting in less accurate quantification. Overall, the
stoichiometries are consistent with the native-like architecture of PEG arrays, which have
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high CheA occupancy observed by electron cryotomography (Briegel et al., 2014a). Thus
PEG mediates assembly via molecular crowding that does not require the His-tag; both
vesicle and Ni(II) assembly require the His-tag to mediate assembly of complexes with
comparable kinase activity and protein stoichiometry.
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Figure 3.3. The His-tag is required for metal-mediated assembly. (A) Cartoon depicting
constructs tested to determine the role of the His-tag (H6, red box) in metal-mediated
assembly of active complexes. (B) Specific activity of CheA kinase assembled with
CheW and His-tagged receptor (black for H6CF or gray for H6TEV-CF) or non-Histagged receptor (striped for ΔH6CF). Activities are averages of four to eight replicates
measured on two to four days; error bars indicate ± one standard deviation. (C)
Stoichiometries for active complexes determined as the ratio of proteins in the
sedimented complexes. The ~25–28 µM sedimented CF was set to 6 for calculations of
the relative amounts of bound CheA (blue) and CheW (cyan), based on ratios of band
intensities in SDS-PAGE of sedimented complexes. Horizontal solid and dashed lines
correspond to native 6:1:2 molar stoichiometries. Stoichiometries are averages of two to
four replicates measured on two to four days; error bars indicate ± one standard
deviation. Error bars are either large or missing for CheW stoichiometries in PEG
complexes, due to gel distortions from PEG in the CheW molecular weight range.
Reprinted (adapted) with permission from (Haglin et al., 2017). Copyright 2017
American Chemical Society.
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3.2.4. Metal-mediated complexes form native-like arrays
Chemoreceptor complexes with CheA and CheW form an extended lattice of
hexagonal arrays located within the bacterial inner membrane that is responsible for
ensuring a sensitive and integrated response to chemical gradients. Because ternary
complex formation and kinase activity have been observed in the absence of arrays,
(Boldog et al., 2006; Swain et al., 2009; Greenswag et al., 2015) we used electron
cryotomography (ECT) to assess the structural features and homogeneity of the metalmediated complexes. ECT images of both Ni(II)- and Zn(II)-mediated H6CF ternary
complexes prepared under conditions leading to maximal activity reveal clear highcontrast hexagonal lattices (Figure 3.4A and Figure 3.5). ECT results show that Zn(II)mediated complexes are less abundant and the patches are smaller compared to Ni(II) or
PEG. This may be due to less rigorous optimization for Zn(II) assemblies. Perhaps excess
Zn(II) incorporation into the proteins (3–4 Zn per H6CF compared to 1 Ni per H6CF,
Table 3.1) may somehow perturb extended array formation. Despite their small size,
subvolume averaging for Zn(II) complexes was still achieved. With 12 nm center-tocenter spacing between hexagons, both metal-mediated arrays are indistinguishable from
in vivo arrays and from our other in vitro assemblies formed with templating-vesicles and
PEG-mediated crowding (Briegel et al., 2014a). Interestingly, metal-mediated arrays also
form the sandwich-like structures seen with PEG (Figure 3.4B). This architecture is likely
necessary to stabilize the membrane-proximal ends of the long CF in the absence of
organization by a membrane.
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Figure 3.4. Ni(II)-mediated functional complexes form native-like arrays. Tomographic
slices of (A) Ni(II)-mediated H6CF and (B) PEG-mediated H6CF show both top down
patches of hexagonal arrays (white arrows) and side view sandwich-like structures (black
arrows) made from two layers of CF with overlapping N- and C-termini that are
sandwiched between baseplates of CheA and CheW on the outside. Scale bars are 50 nm,
and insets show enlarged subvolume averages of the hexagonal array with the canonical
12 nm center-to-center spacing (dotted lines in A and B insets are 12 nm) that is identical
to in vivo arrays (Briegel et al., 2012, 2014a). Reprinted (adapted) with permission from
(Haglin et al., 2017). Copyright 2017 American Chemical Society.
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Figure 3.5. Zn(II)-mediated complexes form small native-like arrays. Tomographic slice
showing Zn(II)-mediated H6CF ternary complexes assembled under maximally active
conditions. Native-like hexagons (white arrows) with 12 nm center spacing and side view
sandwich architecture (black arrows) indicate similar structural features as Ni(II) and
PEG arrays. Scale bar is 50 nm. Inset shows subvolume average of single hexagons; scale
bar is 10nm. Reprinted (adapted) with permission from (Haglin et al., 2017). Copyright
2017 American Chemical Society.
To further investigate the structural similarities between arrays assembled by
these methods, we measured the baseplate distances between CheA/CheW layers for
three assemblies that formed sandwiches. Figure 3.6, a plot of the intensity of the 3D
volume of the side view for Ni(II)-mediated H6CF, PEG-mediated H6CF, and PEGmediated ΔH6CF sandwiches (examples in left panels of Figure 3.6), reveals identical
distances of 33 nm between baseplates. Given an approximate H6CF receptor length of
~21.8nm (145 residues, assuming all alpha helical) from the N-terminus to the
membrane-distal tip, a 33 nm sandwich thickness (Figure 3.6) predicts that CF’s from
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each side of the sandwich overlap with each other in the central ~10.6 nm region. This
may be consistent with the disorder (low electron density) observed in the central ~1/3 of
the sandwich, as seen in a side view of the isosurfaces of electron density calculated by
subvolume averaging of tomograms for Ni(II) and PEG-mediated H6CF (Figure 3.7).
Remarkably, the similarity in baseplate distances indicates that the overlap interactions
that stabilize the sandwich assembly do not depend critically on what stabilizes the
complexes (metal or PEG) or on the sequence of the N-termini (H6CF vs. ΔH6CF) that
are present in the overlap region. Ultimately, the similarity in the architecture of the PEGassembled H6CF and ΔH6CF arrays indicates that the ECT resolution is not sufficient to
detect whatever differences in structure and dynamics account for the 2-fold difference in
kinase activity (Figure 3.3B) between these samples.
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Figure 3.6. Estimating baseplate distances using tomographic 3D volume intensities.
(Left panels) Five individual sandwiches for Ni(II)-mediated H6CF (red), PEG-mediated
H6CF (blue), and PEG-mediated ΔH6CF (green) ternary complexes were selected and
centered at the identical 3D dimension. For each sandwich structure, 20 slices
(corresponding to 7 nm of depth) were integrated into one image to enhance the contrast.
Intensities for each image were measured based on the gray value and plotted along the
distance measured in pixels (right) in ImageJ. The dip in intensity corresponds to the
baseplates composed of CheA and CheW, revealing identical sandwich lengths of 33 nm
for all samples. Scale bars are 20 nm. Reprinted (adapted) with permission from (Haglin
et al., 2017). Copyright 2017 American Chemical Society.
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Figure 3.7. Ni(II) and PEG assembled H6CF complexes have similar electron densities
that overlap with native chemoreceptor arrays. Isosurface representation for H6CF
assembled with Ni(II) (isosurface in yellow for panel A and B) or PEG (isosurface in
purple for panel C and D). The cyan mesh represents the density of in vivo hexagonally
packed chemoreceptor arrays from E.coli (EMDB ID: 2158) (Briegel et al., 2012). Side
view shows sandwich architecture for two layers of trimers-of-dimers (B, D). Top down
view (A, C) show two layers of receptor hexagons illustrating that trimers of dimers are
vertically aligned in the sandwich. In both Ni(II) (A) and PEG (C) samples, the
hexagonal packing of receptors closely fit with the electron density map of the native
intact chemoreceptor array. Overlay of maps was done manually in Chimera; density
thresholds were chosen to highlight the receptor array similarity between different arrays.
Reprinted (adapted) with permission from (Haglin et al., 2017). Copyright 2017
American Chemical Society.
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3.2.5. Receptors dimerize and oligomerize with metal
The results presented above suggest that metal binds to the His-tag of H6CF and
somehow stabilizes formation of the functional, native-like array with CheA and CheW.
Within the native architecture, what interactions could be stabilized by metal bridging
two His-tags? The N-terminal His-tags are likely to be near each other within the H6CF
dimer. In contrast, His-tags on two different dimers are not adjacent in the trimer-ofdimers (as shown in Figure 3.8A, they are ~50 Å apart in the ECT-derived structural
model, Protein Data Bank entry 3JA6 (Cassidy et al., 2015)) and His-tags on the two
H6CF layers are not likely to be adjacent in the sandwich (they are on opposite sides of
the ~10 nm overlap region, Figure 3.8B). Thus, it seems likely that metal binding bridges
two His-tags within a H6CF dimer, and stabilization of the dimer drives assembly of the
functional array. To investigate this, we monitored the formation of metal-mediated
complexes of H6CF using size exclusion chromatography coupled with multi-angle light
scattering (SEC-MALS).
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Figure 3.8. Approximate His-tag-to-His-tag distances in chemoreceptor structural
models. (A) In the ECT-derived model containing the Thermatoga maritima receptor
trimer of dimers (PDB code 3JA6 (Cassidy et al., 2015)), the residues corresponding to
the end of the CF His-tag are shown as red spheres on each monomer. Within a single
dimer, His-tags are 10–15 Å apart, while across the trimer interface can be from 50–65 Å,
depending on the rotation of the helices. (B) Another structural model was made by
docking the E. coli serine receptor dimer (PDB 1QU7 (Kim et al., 1999)) into ECT
density of sandwiched PEG arrays. In this model, the His-tags (red spheres) are more
than 80 Å apart across the receptor membrane proximal overlap region. Coordinates for
this model were a gift from Ariane Briegel.
Complex formation of H6CF alone provided the best means of assessing the effect
of metal on the H6CF monomer–dimer equilibrium, because the CF dimer cannot be
resolved from CheA (see Chapter 4). We anticipate that binding of Ni(II) to the H6CF
His-tag is similar in the presence and absence of CheA and CheW, because ICP-OES
indicates 1:1 binding in both cases. As discussed above, incubation of H6CF alone with
NiCl2 results in sedimentable aggregates. Apparently, these aggregates can become too
large to pass the 0.22 µm precolumn filter, as the total eluted protein was observed to
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decrease over the time course of the experiment (Table 3.2). Figure 3.9A shows the
overlaid chromatograms from the time course series, all scaled to the same total
integrated peak area. The amount of aggregate lost in the precolumn filter (dashed line in
Figure 3.9B) was calculated from the decrease in area with each injection. To quantify
the fraction of monomer, dimer, and oligomer, elution time ranges were set at the points
of minimum A280 between peaks (Figure 3.9A, gray vertical lines at 10, 11.7, 12.8, and
15.5 min), and these peak areas were used to calculate the percentage of H6CF in
monomer, dimer, and oligomer forms (Figure 3.9B).
Table 3.2. Amount of Ni(II)-induced H6CF aggregation increases with time.a
Incubation timeb

Aggregate (%)e

Scaling factorf

No NiCl2

Total Elution UV
Peak Area (A.U.)d
0.0268

0

1

<1 minc

0.0260

3.0

1.03

30 min

0.0214

20.1

1.25

1h

0.0174

35.1

1.54

2h

0.0144

46.3

1.86

3h

0.0127

52.6

2.11

4h

0.0079

70.5

3.39

a

30 µM H6CF with 180 µM NiCl2.
Aliquots were injected from a single large volume sample, to prevent sample-to-sample
variation, except for a separate “No NiCl2 ” sample of 30 µM H6CF alone.
c
The minimum amount of time required to add NiCl2 to H6CF and inject it onto the SEC.
d
Measured across total elution time (10–15.5 min) using ASTRA VI.
e
Calulated as (1–[(Total Peak Area)/(“No NiCl2” Total Peak Area)])×100. Data also
plotted in Figure 3.9B.
f
Calculated as (“No NiCl2” Total Peak Area)/(Total Peak Area). Used to scale
chromatograms presented in Figure 3.9A.
b
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SEC-MALS of H6CF incubated with 180 µM NiCl2 (Figure 3.9) demonstrates
that Ni(II) stabilizes the H6CF dimer. Prior to the addition of NiCl2, the monomer:dimer
ratio is approximately 10:1 (Figure 3.9, red) based on the integrated UV peak area ratio
of 5.1:1 (area of the dimer peak divided by two gives dimer concentration). Strikingly,
within the minimal time to add metal to the protein and inject it onto the column (<1
min), there is a significant decrease in the monomer:dimer ratio to 3.7:1 (Figure 3.9,
orange), which corresponds to a 2.7-fold decrease in this ratio. At remaining time points,
both monomer and dimer concentrations continue to decrease in parallel, due to a
significant increase in the aggregate fraction (Figure 3.9B, Table 3.2). The system is not
at equilibrium, but the monomer to dimer ratio remains in the range of 6–8:1, consistent
with Ni(II) stabilization of H6CF dimers.

Figure 3.9. Ni(II) stabilizes the H6CF dimer, which in turn favors larger oligomers. (A)
SEC-MALS chromatograms of 30 µM H6CF incubated with 180 µM NiCl2, colored by
rainbow according to the increasing incubation time. Vertical lines indicate elution time
bounds used to distinguish the monomer (12.8–15.5 min), dimer (11.7–12.8 min), and
oligomers (10–11.7 min). Although identical volumes (75 µL) of the same sample were
injected, some H6CF aggregate was caught in the precolumn filter. Chromatograms are
scaled to the same total area to account for aggregated protein (B, dashed line). (B) The
peak areas of the monomer (circle), dimer (triangle), and oligomers (square) were used to
calculate the amount of H6CF in each state for all incubation times. The percent H6CF in
aggregates larger than the 0.22 µm pre-column filter (dashed line, listed in Table 3.2) was
calculated from the loss of area under the SEC elution curve. Reprinted (adapted) with
permission from (Haglin et al., 2017). Copyright 2017 American Chemical Society.
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3.2.6. Ni(II) promotes partially reversible H6CF aggregation and fibril formation
Chemoreceptors have been observed to form alternate non-native structures in the
absence or with insufficient quantities of their cytoplasmic binding partners, CheA and
CheW. In particular, so-called “zippers” with interdigitation of the receptor cytoplasmic
tips have been reported for overexpressed receptors in vivo (Lefman et al., 2004; Zhang et
al., 2007), reconstituted intact receptors (Weis et al., 2003), and CF assembled on
templating vesicles (Montefusco et al., 2007). A more detailed analysis of the
overexpressed intact receptors revealed hexagonal packing with 9 nm center-to-center
spacing that is distinct from that of the wild-type 12 nm arrays observed in both
membrane-bound and sandwich architectures (Briegel et al., 2014a). Thus we expected
that the Ni(II)-induced aggregation in the absence of CheA and CheW would produce a
similar zipper-like structure. Instead, ECT images (Figure 3.10A) demonstrate these
conditions yield a mixture of nonspecific aggregates and fibrils with uniform 7 nm widths
but varying lengths (40–105 nm). Therefore we have identified yet another structure
formed by CF in the absence of CheA and CheW: double-stranded fibrils. Interestingly,
these fibrils and aggregates are at least partially reversible: addition of CheA and CheW
after pre-incubation of H6CF with NiCl2 can produce complexes with kinase activity that
is 80% of that of normal complexes assembled by adding NiCl2 last (Figure 3.10B).
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Figure 3.10. Ni(II) promotes partially reversible H6CF aggregation and fibril formation.
(A) Tomographic slice shows that H6CF incubated with NiCl2 without CheA or CheW
forms non-specific aggregates (black arrows) and double-stranded fibrils (white arrows) 7
nm in width. Scale bar is 50 nm. (B) Onset of kinase activity comparing normal assembly
to pre-incubation of NiCl2 with H6CF before assembly reveals that aggregation induced
by pre-incubation is partially reversible. For normal assembly (filled circles), 180 µM
NiCl2 was added last to initiate assembly. Pre-incubation (open circles) of NiCl2 with
H6CF for 15 minutes was done prior to addition of CheA and CheW to initiate assembly.
Activities are averages of four replicates measured on two days; error bars indicate ± one
standard deviation. Pre-incubation activity is plotted as % of maximum normal assembly
activity on the same day. Reprinted (adapted) with permission from (Haglin et al., 2017).
Copyright 2017 American Chemical Society.
3.2.7. PEG and metal promote assembly of CF4E kinase-off state
The CF4E version of the aspartate receptor has four glutamic acid residues, as
does the native non-methylated state. It forms complexes with CheA and CheW when
assembled on vesicles, but crowding of the complexes is needed to force CF4E into a
kinase-on state (Besschetnova et al., 2008). CF4E also does not form arrays under PEGmediated assembly conditions (no significant sedimentation or kinase activity). The
sandwich architecture of metal and PEG assemblies places the added charge of the
glutamic acid in CF4E in the overlap region thus, effectively doubling the negative
charge in that region. Thus electrostatic repulsion is likely to hinder formation of
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sandwich arrays. However, we observed significant sedimentation of CF4E (63%) under
conditions for Ni(II)-mediated assembly of complexes. On the other hand, only 11%
sedimentation occurs in the absence of CheA and CheW, presumably because
electrostatic repulsion opposes the metal-induced aggregation observed for CF4Q. Since
Ni(II) and PEG promote assembly of sandwiches by different mechanisms, we
hypothesized that combining NiCl2 and PEG together would increase the level of
complex formation and that the resulting complexes would be in the kinaseoff/methylation-on signaling state.
To test these hypotheses, we prepared complexes of CF4E with NiCl2 or NiCl2 +
PEG and measured the both kinase activation and methylation (Figure 3.11; methylation
upon incubation with CheR and SAM results in a gel shift due to faster migration). Both
conditions yielded sedimentable complexes with native-like stoichiometries (Table 3.3).
To assess the signaling state of these complexes, we compared their kinase and
methylation activities to those of NiCl2-assembled CF4Q complexes representing the
kinase-on/methylation-off state and vesicle-assembled CF4E.A411V (Ames and
Parkinson, 2006) representing the kinase-off/methylation-on state. Remarkably, all CF4E
complexes exhibit some degree of methylation and no kinase activity, leading us to
conclude they are in the kinase-off/methylation-on state.
Importantly, the methylation assay (gels shown in Figure 3.11B and C) was done
on the full assembly sample and thus reflects methylation of both complexed and free
CF4E. Free CF4E is not significantly methylated, as previously shown (Shrout et al.,
2003) and as indicated by the results for Ni(II)-assembled CF4E in the absence of CheA
or CheW (predominantly free, since only 11% sedimentation, and only 9% of total CF
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methylated after 4 h). We therefore assumed that all methylation occurs on the
complexed CF4E and report the %methylated-CF divided by the % sedimented-CF in
Table 3.3 to indicate the percent methylation of complexed CF4E under each assembly
condition. As hypothesized, the addition of PEG to NiCl2 improves complex formation
(63% sedimentation with NiCl2 versus 93% for NiCl2 + PEG), but it is possible that the
higher CF4E concentrations used for the PEG assembly may account for the some of the
increase in complex formation. The total methylation of CF4E complexes at 4 hours is
comparable (80-90%) for all of the metal assembly conditions. There are differences in
the methylation at 0.1 hour, which may reflect a difference in methylation rates;
additional experiments and controls are needed to investigate this possibility.

Figure 3.11. NiCl2 and NiCl2 + PEG promote assembly of CF4E in the methylation-on
and kinase-off state. Kinase activity (A) and methylation (B, C) of CF4E assembled
under various conditions. Control samples are NiCl2-assembled CF4Q for the kinaseon/methylation-off state, vesicle-assembled CF4E.A411V for the kinase-off/methylationon state. An additional control for the methylation assay is NiCl2 CF4E (–SAM, sadenosyl-L-methionine) that lacks the substrate for methylation. All CF4E complexes
assembled with NiCl2 (with or without CheA and CheW) and NiCl2 + PEG exhibit little
to no kinase activation (A) but do show methylation in the gel shift assay (C, quantified
in Table 3.3). Gels (B, C) were cropped to show only CF, methylated-CF (meth-CF), and
CheR for clarity.
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Table 3.3. Sedimentation, stoichiometry, and % methylation of CF4E complexesa
Assembled Complexb

Sedimented
CFf
µM
%

Stoichiometry

g

Methylated-CF
(%)i
0.1 h
4h

CF (µM)

Methode

A/W

4Q

Ni(II)

+

25.6

85

6:1.5:3.5

N/A

N/A

4E.A411V

Vesicle

+

27.7

92

6:1.1:1.9

11

75

4Ec

Ni(II)

–

3.2

11

N/Ah

9

80j

4E

Ni(II)

+

19.0

63

6:1.4:2.8

26

81

4Ed

Ni(II) +
PEG

+

46.6

93

6:0.9:2.1

44

90

a

Corresponding kinase and methylation data presented in Figure 3.11.
Protein concentrations 30 µM CF, 12 µM CheA, and 24 µM CheW, except as noted.c,d
c
No CheA or CheW present in this 30 µM CF4E sample.
d
Sample contains 50 µΜ CF, 12 µM CheA, and 20 µM CheW.
e
Ni(II)-mediated complexes contain 180 µM NiCl2; Vesicle-mediated complexes contain
725 µM lipid (290 µM DOGS-NTA-Ni2+ and 435 µM DOPC); Ni(II) + PEG-mediated
complexes contain 180 µM NiCl2, 7.5% w/v PEG8000, and 4% w/v D-trehalose.
f
Quantified from sedimentation assay (see section 2.4.2).
g
Calculated stoichiometries of CF:CheA:CheW from pellet lane ratios in sedimentation
assay (see section 2.4.2).
h
Not applicable as no CheA or CheW is present.
i
Quantifed from gel shown in Figure 3.11. %Methylated-CF = [(Imeth-CF)/( ICF + Imeth-CF)]/
%Sedimented-CF.
j
Corrected values indicate the sedimented free CF4E is predominantly methylated, but it
accounts for only 9% of the total CF4E.
b

The sandwich architecture exhibited by PEG and Ni(II)-mediated arrays have thus
far only been observed for CF4Q arrays. Is it possible for CF4E assembled with Ni(II)
and PEG to retain the sandwich architecture despite electrostatic repulsion? To answer
this, we returned to ECT to image Ni(II) + PEG-mediated CF4E arrays. Previous ECT of
CF4E was limited to vesicle-assembled arrays, which tend to have lower resolution due
to vesicle curvature (Briegel et al., 2014a). Ideal chemoreceptor candidates for ECT are
thin, flat, and highly ordered (Briegel and Jensen, 2017).
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While the high concentrations of PEG led to thicker blots on the ECT grids (Wen
Yang, personal communication), the first look at Ni(II) + PEG-mediated CF4E
complexes (Figure 3.12) clearly indicates the presence of sandwich arrays that retain the
12 nm hexagonal array spacing. Unfortunately the collected tomograms show a tendency
of these arrays to form thick clumps that lack enough order to assign specific structures.
Moreover, an error in data acquisition may have contributed to lower quality tomograms
(Wen Yang, personal communication). However, a few small yet distinctive structures
were visible, including a single hexagon (Figure 3.12A, B) and a sandwich (3.12C).

Figure 3.12. CF4E assembled with Ni(II) and PEG exhibit hexagon and sandwich
architecture. Tomographic slices show predominately low-order aggregation due to PEG
and non-ideal experimental conditions with the exception of a single hexagon cluster
(white arrow in A that is zoomed-in in B) and a sandwich structure (C) from elsewhere in
the tilt series. Scale bars indicate 50 nm in A and 20 nm in B and C.
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This newfound ability to image CF4E in sandwiches provides a unique
opportunity to investigate structural changes of signaling and receptor methylation state
in the context of the array. For example, how does the disordered region observed for
CF4Q (Figure 3.7) compare to CF4E? Does the added electrostatic interaction alter the
structural stability in the predominately disordered membrane proximal region?
Additionally, the ligand-induced expansion model predicts this region would exhibit the
largest conformational change in which the trimers of dimers are spread farther apart in
the kinase-off/methylation-on state (Sferdean et al., 2012). Until now, preparing CF
complexes in this signaling state were limited to: (1) CF4E on low-density vesicles, (2)
CF4E.A411V on high-density vesicles, or (3) CF4Q.A411V on high-density vesicles,
PEG, or metal. It’s been shown that vesicle assemblies are limited in resolution due to
curvature, so we imaged CF4Q.A411V on PEG or metals to probe the structure of the
kinase-off/methylation-on state. Unfortunately no measureable differences were observed
compared to CF4Q (data not shown). Recent work from Briegel and coworkers reported
no conformational changes for various signaling-related mutants of the Tsr receptor, but
did observe distinct differences in the associated CheA density, particularly for lockedoff mutants (Briegel et al., 2013).
Moving forward, we propose that investigating the structure, disorder, and CheA
density of CF4E arrays assembled into sandwiches in the kinase-off/methylation-on state
may provide new insights into signaling mechanism. However, we note that experimental
conditions will need to be optimized to minimize thickness on ECT grids (perhaps by
decreasing PEG concentrations) and to maximize array size (perhaps by increasing PEG
or protein concentrations). Alternatively, CF4E with Ni(II) alone avoids PEG, but further
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optimization may be needed to fully form sedimentable complexes as current conditions
only obtain 63% complexation (Table 3.3).

3.2.8. Metal-assembled complexes are stable after removing metal
We have demonstrated that metal-mediated assembly involves metal binding to
the His-tag to stabilize CF dimers. Assuming excess metal is needed to drive the metal
binding equilibrium, can the metal be removed without disrupting the array? To
investigate this, we monitored activity and complexation over time of Ni(II)-mediated
H6CF complexes following the addition of the metal chelator EDTA. Ni(II) has a much
higher affinity for EDTA than for hexahistidine-tags on proteins [EDTA KD ≈ 4×10–19 M,
6His-tagged protein KD ≈ 10–6 M (Knecht et al., 2009)]. Therefore, we assume that
adding stoichiometric EDTA (180 µM) will chelate the 150 µM unbound Ni(II) (180 µM
total Ni(II) – 30 µM H6CF-bound Ni(II)) immediately. It’s unclear, however, how
quickly the Ni(II) bound to H6CF will be removed by the EDTA. To limit dilution
effects, a small amount (2.5% of the total complex volume) of a highly concentrated
EDTA stock was added to assembled Ni(II)-mediated complexes. We then measured the
kinase activity and sedimentation after 30 min, 2 h, and 24 h, all kept at 25°C (Figure
3.13).
Remarkably, Ni(II)-mediated complexes do not immediately fall apart following
the addition of EDTA. In fact, complexes remain 90% intact after 2 h, and ~70% after 24
h (Figure 3.13B), suggesting the arrays are kinetically stable. Perplexingly, we see a
larger decrease in kinase activity: 88% activity was retained after 2 h, which dropped to
46% after 24 h. Without the addition of EDTA, metal-mediated arrays are ~90% active
after 4 days, but this long-term stability may partially be a result of storing the complexes
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at 4°C (not shown). Combined, these results suggest that metal removal causes both a
loss of complexes and a decrease in activity of the remaining complexes.
Our results clearly indicate the arrays are kinetically stable for a few hours once
assembled. We cannot, however, distinguish whether these are metal-bound complexes
(if metal does not immediate dissociate) or metal-free complexes (EDTA strips out metal
faster than complex dissociation). In the case of metal-free kinetically stable complexes,
this suggests that arrays can be stabilized by protein–protein interactions alone.

62

Figure 3.13. EDTA causes slow disassembly and loss of kinase activity of Ni(II)mediated H6CF complexes. Total kinase activity (A) and sedimentation (B) was
measured 30 min, 2 h, and 24 h following the addition of 180 µM EDTA to Ni(II)assembled complexes and incubated at 25°C. Activity and sedimentation data are
normalized to the Ni(II) control sample prior to addition of EDTA (total activity of 8.7 s–1
and sedimentations of 23 µM H6CF, 4.4 µM CheA, and 7.8 µM CheW).
3.3. Summary and Conclusions
In this chapter we’ve demonstrated a novel method for triggering assembly of the
aspartate chemoreceptor cytoplasmic fragment (CF) into nanoarrays through metalmediated His-tag dimerization and compared these to other in vitro native-like arrays.
Functional complexes of CF, CheA, and CheW form upon addition of specific divalent
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metals and assemble into an extended hexagonal lattice that exhibits the widely
conserved (Briegel et al., 2009, 2011), native 12 nm center-to-center spacing (Figure 3.4).
Intact chemoreceptor arrays are normally stabilized by a combination of anchoring in the
membrane and cytosolic binding of CheA and CheW in rings at the membrane-distal
cytoplasmic tip of the receptor. In current structural models of the complex, the long
(~200 Å) cytoplasmic domain has protein–protein interactions with itself, CheA, and
CheW only at its membrane-distal end, so the constraints imposed by its transmembrane
and periplasmic domains are likely critical to the stability of the array. The necessary
membrane-proximal stability to form CF arrays can be achieved with a membrane
mimetic (templating vesicles) (Shrout et al., 2003) or with a sandwich architecture
produced with PEG (Fowler et al., 2010) or divalent metals (this work). Importantly, all
three in vitro preparations with CF yield high CheA occupancy and native stoichiometry
(Figure 3.3C), although PEG arrays have previously been shown to lack the alternating
hexagons of CheA observed for in vivo arrays (Briegel et al., 2014a). Measured CheW
stoichiometries of 2 monomers per 6 CF monomers in these assemblies provide further
evidence of CheW-only rings that are proposed to provide structural integrity to the array
(Liu et al., 2012; Cassidy et al., 2015).
In contrast to the non-native “zippers” that form with cytoplasmic tips
interdigitated in the center in the absence of sufficient CheA and CheW, “sandwiches”
have receptors oriented in the opposite direction: cytoplasmic tips interact with
CheA/CheW rings on both surfaces of the sandwich, forming hexagonal arrays with the
canonical 12 nm center-to-center packing. Although sandwiches are not the native
architecture for the E. coli aspartate receptor used in this study, similar cytoplasmic
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arrays exhibiting both 12 nm hexagonal lattices and sandwich architectures are observed
for cytoplasmic chemoreceptors (lacking transmembrane domains) from a variety of
bacteria and archaea, including Vibrio cholerae (Briegel et al., 2016), Rhodobacter
sphaeroides (Briegel et al., 2014b), and Methanobacterium formicicum (Briegel et al.,
2015).
The observed metal dependence of assembly is consistent with the proposed Histag dimerization mechanism. The relative efficiency of the divalent metals in promoting
active complex formation, Ni(II) > Zn(II) > Co(II), follows the relative affinities of these
metals for peptides containing multiple His residues (Sovago et al., 2016). This is
consistent with preliminary X-ray absorption spectroscopy (XAS) data (Hsin-Ting Huang
and Michael J Maroney, unpublished observations) suggesting that the Ni(II) bound to
H6CF is coordinated by 6 ligands, including multiple histidines. Importantly, knowing
Ni(II) is 6-coordinate and therefore paramagnetic suggests it may be possible to obtain
distance constraints with paramagnetic relaxation enhancement NMR experiments
involving comparison to the diamagnetic Zn(II)-assembly that has identical array
architecture by ECT (Figure 3.5). This could provide critical structural information in the
overlap region of the sandwich where electron density is lost in ECT (Figure 3.6).
Assembly of large multiprotein complexes in vitro that retain native structure and
function is a challenging but essential step in understanding how protein machines
operate in the cell. His-tag-mediated dimerization is a means of stabilizing protein dimers
that is much less perturbing than fusion to a protein dimerization motif. For example,
fusion to a leucine zipper (LZ) introduces 30–60 residues, which is more perturbing than
a polyhistadine-tag and can interfere with assembly of native complexes. Interestingly,
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fusion of a 45-residue LZ to the chemotaxis receptor CF used in our study restored kinase
activation but perturbed the assembly of native complexes with CheA and CheW. The
LZ-CF assembled into sandwich-like particles in the opposite orientation (two CF layers
on the outside of a middle layer of CheA and CheW) that prevented formation of the
native array (Francis et al., 2002, 2004; Wolanin et al., 2006). This comparison of LZ and
His-tag-mediated dimerization of the same system demonstrates that using the least
perturbing means of stabilization protein interactions can be critical to assembling native
complexes. This approach has significant potential for application to other multiprotein
systems, for the stabilization of functional complexes with native architecture. His-tags
are widely used and they are easily introduced at many locations within a recombinantly
expressed protein. This should make it possible to drive dimerization at a known dimer
interface with minimal perturbation to structure or function, for straightforward and
accurate in vitro studies of the mechanisms of key processes in the cell.
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CHAPTER 4
INSIGHTS INTO THE MODE OF CHEMORECEPTOR ARRAY FORMATION
AND KINASE ACTIVATION
This chapter reports on the assembly mechanisms that govern formation of
hexagonally packed chemoreceptor arrays in complex with CheA and CheW. The metalmediated assembly technology (described in Chapter 3) enabled the first experimental
observation of the early stages of assembly. Most of this chapter was published in the
article “His-tag-mediated dimerization of chemoreceptors leads to assembly of functional
nanoarrays” in Biochemistry (Haglin et al., 2017).

4.1. Introduction
As discussed in the previous chapter, structure–function analyses of protein
assemblies in vitro that mimic native systems require a high degree of homogeneity in
isolating or reassembling such multiprotein complexes. This is particularly challenging
when proteins must be altered (i.e. truncation or mutation) to facilitate in vitro
preparations. Moreover, the shear size of large protein assemblies such as chemoreceptor
arrays can impart an additional challenge to perform accurate and precise biophysical
studies. However, it remains unclear whether reassembly of the full array is necessary to
understand the architecture and molecular mechanisms of chemotaxis signal transduction.
An in vitro reconstitution of intact receptors as trimers of dimers into nanodiscs revealed
that the core unit involved in the chemoreceptor array is an independent signaling unit
capable of all chemosensory functions, including ligand binding, transmembrane
signaling, adaptation modification, and kinase activation/control (Boldog et al., 2006; Li
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and Hazelbauer, 2011; Li et al., 2011). Additionally, the nanodisc-assembled core units
contained a stoichiometry of six receptors to one CheA and one CheW. This is at odds
with the mounting evidence for CheW-only rings seen by ECT (Liu et al., 2012; Cassidy
et al., 2015), and the stoichiometries we measured for three in vitro native-like arrays (see
Chapter 3), which indicate native stoichiometry is 6:1:2. Thus, when and how does the
additional CheW get incorporated into the array if it is not present in the core unit?
To answer these questions, we must first understand how the array assembles. The
current model (Liu et al., 2012; Briegel et al., 2014a; Briegel and Jensen, 2017) predicts
that array formation starts with assembly of trimers of dimers that subsequently form core
units by binding CheA and CheW. Core units then merge into hexagons that grow into a
full array through incorporation of additional core units. This model is based on ECT data
showing the existence of linked trimers of dimers, single hexagons, linked hexagons, and
patches of hexagons in preparations of isolated native membranes reconstituted with
overexpressed receptor and excess CheA and CheW. This ECT study did not follow the
time course of assembly. ECT cannot detect disordered species, including all of the
separate protein components, and also cannot quantify the ordered species present in a
sample. A complementary approach is needed to follow the time course of array
assembly.
As presented in this chapter, we used our novel metal-mediated assembly method
to investigate chemoreceptor array formation. Advantages of this method include the
ability to trigger the assembly in solution and monitor the kinetics of the onset of activity
and the formation of complexes. Moreover, by eliminating the vesicle and PEG
components needed for vesicle-mediated and PEG-mediated assembly, we were able to
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use SEC-MALS to separate and follow the components and complexes, and deduce when
CheA and CheW are incorporated into the array. Lastly, we correlated the extent of
kinase activity with array size, leading to a proposal that allosteric effects within the array
contribute to the overall signaling output.

4.2. Results and Discussion
4.2.1. Kinetics of kinase activity and binding
To understand the mechanism of metal-mediated formation of functional
complexes, we investigated the assembly kinetics by measuring the onset of kinase
activity and sedimentation immediately after combining the H6CF, CheA, CheW, and 180
µM NiCl2. Assembly with either vesicles (Montefusco et al., 2007) or PEG (unpublished
observations) requires incubation at 25°C for at least 4 h before maximal activity is
reached. Although the NiCl2 assembly activity similarly achieves maximal activity after 4
hours (Figure 4.1), the sedimentation profile shows nearly complete binding (80-90%) of
all three proteins within the first 30 min. Note that complex formation may continue
during the 30 min centrifugation, whereas the kinase activity measurements take < 2 min;
therefore complete binding occurs at 30–60 min. Thus, the kinase activity is only 40–
60% when the CheA and CheW incorporation is maximal, which suggests that initially
the three proteins bind quickly but further changes are needed to reach maximal activity.
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Figure 4.1. Onset of kinase activation and protein binding of Ni(II)-mediated H6CF
ternary complex assembly. Time course of kinase activity (black circles) and
sedimentation of H6CF, CheA, and CheW (black, dark blue, and cyan bars, respectively)
combined with 180 µM NiCl2. The zero time point is before NiCl2 addition. Activity and
sedimentation data are normalized to their respective maxima, achieved at 4 h (maximum
total activity of 7.6 s–1, and maximum sedimentations of 27.0 µM H6CF, 5.8 µM CheA,
and 13.6 µM CheW). Activities and sedimentation percentages are averages of two
(sedimentation) and four (activity) replicates measured on two days; error bars indicate ±
one standard deviation. Reprinted (adapted) with permission from (Haglin et al., 2017).
Copyright 2017 American Chemical Society.
4.2.2. Ternary complex and array size increases during assembly
We returned to SEC-MALS to monitor complex formation with NiCl2. The three
component proteins and their complexes can be partially resolved via SEC, with the
largest complexes and proteins eluting first, but SEC does not yield accurate molecular
weights from variably shaped proteins like the rod-shaped H6CF. The MALS data enable
the determination of hydrodynamic properties for better estimation of MW. However,
MW estimation is not accurate for overlapping peaks or high-MW complexes that elute
near the void volume (10 min on the SEC-MALS used in this study, details in Chapter 2)
and are highly polydisperse. Separate injections of the individual proteins demonstrate
they are well resolved and that MALS estimates of the molecular masses are reasonably
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close to the actual values (Figure 4.2 and 4.3): the 32.7 kDa H6CF elutes at 13.5 min with
an apparent MW of 34 kDa (black), the 142.7 kDa CheA dimer elutes at 11.5 min with an
apparent MW of 139 kDa (blue), and the 18.1 kDa CheW monomer elutes at 16 min with
an apparent MW of 18 kDa (cyan). These proteins were injected at the concentrations
used for metal-mediated assembly (30 µM H6CF, 12 µM CheA, and 24 µM CheW). The
H6CF peak observed at 12 min with an apparent MW of 73 kDa (black) corresponds to
the 65.4 kDa dimer, but is hidden under the CheA peak once all proteins are combined.
When injected together at the same concentration as the individual injections, ternary
mixtures exhibit apparent molecular weights uniformly increased by 1.3-fold (Figure
4.4). It is not immediately clear why all the MW estimates increase, yet the elution times
exhibit varied changes: CheW elutes faster which is consistent with a MW increase,
while CheA and CF either don’t change, or elute slower, respectively, neither of which is
expected for an increase in MW. One possibility is that an increase in peak overlap makes
MW estimations less reliable.

The two peaks for H6CF and CheW move together

slightly, which could indicate a possible interaction between the two proteins in solution
or on the column. There is also a small shoulder at 10.8 min, which is likely to be a small
amount of ternary complex formation, consistent with the <15% sedimentation observed
under these conditions for an identical sample (0 time in Figure 4.1, which has no Ni(II)).
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Figure 4.2. SEC chromatograms of separately injected ternary components. H6CF
(black), CheA (blue), and CheW (cyan) were injected at concentrations used for assembly
(30 µM, 12 µM, and 24 µM, respectively), as well as a single injection of all three in
solution without NiCl2 (red). Molecular masses estimated from multi-angle light
scattering (MALS) are indicated and are reasonably consistent with the molecular
weights of dimeric CheA (142.7 kDa), dimers and monomers of H6CF (32.7 kDa), and
CheW (18.1 kDa). All chromatograms are normalized to a value of 1 for the largest peak
in the series. Reprinted (adapted) with permission from (Haglin et al., 2017). Copyright
2017 American Chemical Society.

Figure 4.3. Accurate molecular masses are estimated from SEC-MALS of individual
protein injections. Chromatograms for separate 75 µL of each protein at assembly
conditions (30 µM H6CF, 12 µM CheA, and 24 µM CheW) correspond to data in Figure
4.2. Molecular weights corresponding to each protein are averages across each elution
peak. All chromatogram peak heights are normalized to an A280 value of 1 for the CheA.
Reprinted (adapted) with permission from (Haglin et al., 2017). Copyright 2017
American Chemical Society.
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Figure 4.4. Apparent molecular mass estimations from SEC-MALS are higher for
ternary mixtures. As in Figure 4.3, molecular weights corresponding to each protein are
averages across each elution peak. All chromatogram peak heights are normalized to an
A280 value of 1 for the CheA.
The first changes observed by SEC during complex assembly involve primarily
H6CF. The difference between the no NiCl2 and < 1 min with NiCl2 injections (Figure 4.5
and 4.6, red and orange) is a decrease in H6CF peak height and a corresponding increase
in the intensity of a high MW species that elutes at 11.1 min. The latter may consist of
only H6CF oligomers, because there is no significant change in the intensities of the
CheA and CheW peaks. Next, incorporation of CheA and CheW into complexes with
H6CF appears to be nearly complete in 30 min, based on both the sedimentation data
(Figure 4.1) showing nearly complete binding at 30–60 min, and the decrease in the
intensities of the CheA and CheW SEC peaks (Figure 4.5 and 4.6, yellow) with no further
changes at longer time points. CheA and CheW are presumably incorporated into a
complex with H6CF that elutes as a large SEC peak at 11.1 min. While the elution time is
the same as that of the small shoulder seen immediately after the addition of NiCl2
(Figure 4.5 and 4.6, orange), this peak is highly polydisperse and thus likely contains a
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mixture of species with different molecular weights. At longer time points (1–4 h, green
to blue to violet, Figure 4.5 and 4.6), a second peak emerges at 10.5 min (indicated with
arrows) at an even higher MW and the H6CF peak continues to decrease to nearly zero
intensity. These changes coincide with the assembly reaching maximum kinase activity,
as shown in Figure 4.1. The H6CF, CheA, and CheW peaks remaining at 4 h are
consistent with the assembly conditions: large amounts of free CheA and CheW because
these are added in excess, and only ~20% free H6CF, consistent with sedimentation
analysis that typically shows ~10–15% free H6CF after assembly.

Figure 4.5. SEC chromatograms of H6CF, CheA, and CheW incubated with NiCl2 reveal
assembly features. Chromatograms are colored by rainbow according to increasing
incubation time. A high MW complex of H6CF, CheA, and CheW (11 min elution time)
that forms in low yield in the absence of NiCl2 (0 min sedimentation in Figure 4.1, and
red chromatogram also shown in Figure 4.2) and in high yield at early incubation times
(30 and 60 min in Figure 4.1, yellow & green here) sediments but does not have high
kinase activity. The arrow indicates a shift to an even higher MW complex eluting at 10.5
min near the void volume at 10 min elution time. All chromatograms are normalized to a
value of one for the largest peak in the series. Reprinted (adapted) with permission from
(Haglin et al., 2017). Copyright 2017 American Chemical Society.
This experiment was repeated on a second and newer column to test the
reproducibility of the SEC results. In comparing the series in Figure 4.5 and 4.6, some
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interesting differences are apparent. Most notably, a shoulder between CheA and H6CF
that likely corresponds to H6CF dimer can been seen in the new column, indicating
improved separation. Moreover, it disappears sometime between 1–30 min of assembly,
which is consistent with rapid dimer incorporation into oligomers (Figure 3.9) and arrays.
CheA and CheW take longer to fully incorporate (mostly complete after 1 h, with a small
additional incorporation of CheA at 2 h) compared to binding of CheA and CheW in the
previous experiment, which was complete after 30 min (Figure 4.5, yellow). Another
difference is the absence of any complex before the addition of nickel (red), and the fact
the initial small amount of complex formed at <1 min with little or no CheA and CheW
(11 min, orange) is resolved from the dominant complex peak at 10.8 min (yellow and
green). Finally, the larger complex that appears at long times is better resolved from the
initial complex (arrows in Figures 4.5 and 4.6), likely due to improved separation on this
column. While the variations in these results indicate that assembly does not follow an
identical pathway, it’s clear that CheA/W incorporation occurs prior to assembly of the
full size extended array.
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Figure 4.6. Replicate SEC-MALS assembly experiment. Chromatograms of H6CF,
CheA, and CheW incubated with NiCl2, colored and labeled as in Figure 4.4. The
proteins were assembled under identical conditions but injected onto a new column,
resulting in slight variations in elution times. All chromatograms are normalized to a
value of one for the largest peak in the series.
Lastly we must report an unfortunate reality of the SEC-MALS experiments: for
reasons that remain unclear, the two SEC columns used for these studies acquired a CFspecific protease at some point following injection of ternary mixtures. Any variant of CF
(including CF4E, CF4Q.A411V, H6TEV-CF, and CF4Q prepared by Xuni Li and
Maryam Kashefi) experienced nearly complete proteolysis on the column and eluted
predominantly with the buffer components at 22 min. None of the CF variants tested
exhibited proteolysis in an SDS-PAGE, and were fully capable of forming active
complexes (data not shown). It is particularly striking that no other proteins experience
proteolysis. CheA, CheW, BSA, and many other proteins remain completely intact. The
SEC-MALS is maintained by the Institute of Applied Life Sciences core facility and used
by many researchers; none have reported proteolysis problems. Future experiments will
need to avoid SEC-MALS or find a way to prevent proteolysis on a new column.
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4.2.3. Model of chemoreceptor array formation
Characterization of the metal-mediated assembly of CF arrays by activity assays,
sedimentation assays, and SEC-MALS allows us to propose a model for the mechanism
of this assembly (Figure 4.7) and yields new insights into the assembly and properties of
native chemoreceptor arrays. The fast (< 1 min) initial increase in the dimer fraction
(reported in Chapter 3, Figure 3.7) indicates that assembly begins with the stabilization of
CF dimers, most likely by metals bridging two His-tags. Subsequently CheA and CheW
are incorporated with metal-stabilized CF dimers into sedimentable complexes. However,
binding of CheA and CheW is complete within 30–60 min, forming sedimentable
complexes smaller than the fully active complexes that form in 4 h (Figures 4.1, 4.5, and
4.6). While our data cannot distinguish the exact size of these initial smaller complexes,
Figure 4.7 shows one possibility that includes full binding of CheA and CheW into a
sandwich of two core units, each containing 12 CFs (two trimers of dimers), bridged by
one CheA dimer, and also containing four CheW monomers. It is unclear what changes
occur between 1–4 h to yield larger complexes with higher activity that ultimately have
the canonical hexagonal architecture. In one SEC-MALS series (Figure 4.5) there was a
small increase in the level of CF binding, while in another series (Figure 4.6) there was a
small increase in the level of binding of all three proteins. We propose that building to
larger complexes with maximal activity likely involves assembly of core units into
hexagons that coalesce to form larger arrays. This final assembly phase also involves
binding of additional CF, and in some cases of CheA, and/or CheW, to unoccupied sites
in the coalesced array, as it may include rearrangement of CheA and CheW into the
native pattern that maximizes CheA binding in alternating hexagons of CheA/W (Briegel
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et al., 2014a) and only CheW. In any case, it appears that protein–protein interactions
beyond those in the core unit are required for full activity.

Figure 4.7. Model of array assembly by Ni(II)-mediated His-tag dimerization. Cartoon
representation showing progression of assembly starting with CF monomers (side view:
gray bars and top down: gray circles) rapidly forming dimers upon Ni(II) (black dots)
binding to CF His-tags (red line). CheA dimers (blue) and CheW monomers (cyan) bind
to stabilized H6CF dimers to capacity within 30–60 min. Binding of a CheA dimer and
four CheW drive assembly of a pair of trimers-of-receptor dimers into a core unit, that is
likely further stabilized as a sandwich. At longer time points (4 h and beyond), the
assemblies form hexagons and larger arrays with alternating CheA/CheW and CheWonly rings. Reprinted (adapted) with permission from (Haglin et al., 2017). Copyright
2017 American Chemical Society.
4.3. Summary and Conclusions
In this chapter we used our novel in vitro metal-mediated His-tag dimerization
method to trigger formation of arrays and investigate the early stages of how these
proteins assemble into the intricate geometry of the hexagonal array. While the
architectural features of the fully formed array are known (Briegel et al., 2012; Liu et al.,
2012), the mode of assembly has not yet been clearly established given the difficulty of
obtaining snapshots in the context of forming the full array. Thus our metal-assembly
provided a unique and critical opportunity to probe the mode of assembly in vitro.
Moreover, the insights from this study may shed light on how these remarkable arrays
form in the cell.
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Briegel and others (Briegel et al., 2014a) proposed the following model for in vivo
array assembly: (1) receptors dimerize, (2) three receptor dimers form a trimer of dimers,
(3) pairs of receptor trimers of dimers are bridged by a CheA dimer and bind two CheW
to form the core unit, (4) three core units coalesce to form hexagons containing CheA and
CheW, and (5) the array grows through binding of additional core units or of additional
CheA/W-filled hexagons. Our data support the importance of the initial receptor
dimerization in the membrane, since metal-mediated stabilization of the CF dimer is
sufficient to drive array assembly (Chapter 3). We see no evidence for formation of
discrete trimers of CF dimers in the absence of CheA and CheW (Lai et al., 2005), and
instead observe that CF dimers form various oligomers and large aggregates, consistent
with prior observations in vivo (Zhang et al., 2007). We propose that in the absence of a
stabilizing membrane or membrane mimetic, CheA and CheW are required to mediate
assembly of receptor dimers into trimers of dimers. These are then bridged by CheA
dimers into core units that also bind four CheW. This would satisfy all of the receptor
binding sites (2 receptor/CheA interfaces, 4 receptor/CheW interfaces, and 6
receptor/receptor interfaces) and thus prevent non-native interactions that lead to
aggregation both in vitro and in vivo. Our data support incorporation of 4 CheW into the
core unit because there is little additional CheW binding upon assembly of larger arrays
(Figure 4.4). Two of the four CheW in the core unit are weakly bound (lacking the
CheA/CheW protein-protein interaction), and thus would likely be lost during
purification of core complexes with full-length receptors in nanodiscs (Li and
Hazelbauer, 2011) (which contained two CheW per core unit). These weakly bound
CheW are more likely to be retained under excess CheW conditions as in our CF
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assembly conditions. It seems likely that the additional two weakly bound CheW in the
core unit would increase the rate of assembly and, as previously suggested (Liu et al.,
2012), increase the stability of the array. Finally, we propose that assembly of core units
into hexagons is required to achieve maximal kinase activity.
Several important differences are expected between the His-tag mediated
assembly of arrays of receptor fragments and in vivo assembly of membrane-bound
chemoreceptor arrays. Studies of assembly of CF arrays cannot provide insights into the
effects of the missing periplasmic, transmembrane, and HAMP domains, or the effects of
ligand binding (Li and Weis, 2000). Assembly of core units, hexagons, and arrays likely
occurs faster in vivo due to alignment of receptors in the membrane facilitating
encounters by 2D diffusion within the plane of the membrane rather than by 3D
diffusion. Interestingly, although the cellular concentrations of the E. coli chemotaxis
array proteins have been shown to vary significantly with strain and growth conditions,
the protein ratios in the cell remain consistent at 2.9 receptors to 1 CheA to 1.2 CheW (Li
and Hazelbauer, 2004). This excess CheA and CheW is similar to the conditions of our
His-tag mediated assembly of CF arrays, containing a ratio of 2.5 CF to 1 CheA to 2
CheW. Although in vitro assembly does not duplicate the crowded conditions in the cell
that alter protein diffusion rates and affinities, it may be possible to investigate whether
excess CheA and CheW promote assembly as previously suggested (Briegel et al.,
2014a).
In conclusion, we have demonstrated that kinetic analysis with this new assembly
method provides the first experimental evidence that initial binding of CheA and CheW
into ternary complexes proposed to be the “core unit” does not yield high activity, and
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that activity reaches its maximum upon formation of larger arrays. His-tag mediated
dimerization provides a new approach to trigger assembly of native-like chemoreceptor
complexes that avoids the use of PEG and vesicles which interfere with SEC-MALS
analysis. This novel assembly method may prove useful for kinetic analysis of the
assembly of other multi-protein complexes.
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CHAPTER 5
DESIGN AND CHARACTERIZATION OF PARAMAGNETIC RELAXATION
ENHANCEMENTS FOR LONG-RANGE DISTANCE MEASUREMENTS BY
SOLID-STATE NMR
5.1. Introduction
Transmembrane homodimeric chemoreceptor proteins are responsible for signal
transmission in bacterial chemotaxis. These predominantly α-helical proteins relay ligand
binding events from the periplasmic domain to the cytoplasmic subdomains via a 2 Å
piston displacement of the transmembrane signaling helix that is coupled to the conserved
HAMP domain (Miller and Falke, 2004; Hazelbauer et al., 2008). The signaling output
properties of chemoreceptors are characteristic of a two-state model in which kinase-on
and kinase-off outputs are in an equilibrium that shifts depending on ligand occupancy
and receptor methylation state. The latter is a mode of adaptation governed by the
enzymes CheR and CheB that covalently modify receptors at specific sites. Upon high
levels of methylation, affinity for ligand decreases which restores prestimulus kinase
activity. It is not yet clear what molecular mechanisms translate the signal through the
cytoplasmic subdomains to ultimately control the activation or inhibition of the kinase.
One proposal is that trimers of receptor dimers undergo a conformational change
upon ligand binding that alters the activity of CheA. Changes in the spacing between
FRET pairs in the membrane proximal region of Tar and Tsr were correlated to an
expansion with attractant bound (and subsequent kinase inhibition) and a contraction with
repellant bound (with kinase activation) (Vaknin and Berg, 2007). Additionally,
Besschetnova and coworkers observed an apparent receptor density-dependent transition
between the kinase-on and kinase-off states of receptor cytoplasmic fragments assembled
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on vesicles (Besschetnova et al., 2008). High density receptor packing would disfavor
dissociation or expansion, and low density reconstituted intact receptors were shown not
to dissociate (Sferdean et al., 2012). Combined, these data led to a proposed model of
ligand-induced expansion for signal transmission. Given that receptors are anchored at
their membrane-distal cytoplasmic tips into a lattice of rings of CheA and CheW, this
model predicts the largest conformational change occurs in or near the membrane due to
a tilting or straightening of the receptors in the kinase-off or kinase-on state, respectively.
In light of the findings presented in Chapter 4, we must also consider the possibility that
the density-dependent activity could be a result of assembly into hexagons. We found that
kinase activity increases as complexes become larger than the minimal core unit.
Therefore the proposed low-density, kinase-off state may be smaller units that are widely
dispersed on the vesicles that coalesce into more functional arrays upon restricting the
two-dimensional surface area. ECT of such samples has observed some hexagons (Ariane
Briegel, personal communication), but it is not possible to quantify the fraction of CF that
forms hexagons vs. smaller core units. Thus, defining the structural features and
interdimer distances in the membrane-proximal region is needed to test the ligandinduced expansion model.
Although significant progress has been made in resolving some structural features
of chemoreceptors within the array, the membrane-proximal cytoplasmic region remains
elusive. ECT of intact receptors in vivo and receptor fragments assembled into arrays in
vitro (including those presented in Chapter 3) all exhibit density at the membrane-distal
tip of the receptor that gradually disappears closer to the membrane (Briegel et al., 2012,
2014a; Liu et al., 2012; Cassidy et al., 2015). Consistent with this, Liu and coworkers
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reported evidence that the receptor assumes multiple conformations in the membraneproximal portion, (Liu et al., 2012, supplemental Figure S8). Thus structural restraints in
the membrane-proximal region of the chemoreceptor are needed, both to constrain the
dimensions of the trimer of dimers and to test the proposed expansion model by
comparing arrays assembled in defined signaling states. Such distance constraints would
clarify whether the effect of assembly density on kinase activity is due to receptor
expansion/contraction or to a coalescing of core units and hexagons into larger and more
functional arrays.
A number of NMR methods are available to measure distances such as NOEs
(Nuclear Overhauser Effects) and REDOR (Rotational Echo DOuble Resonance).
However, the techniques are limited to distance measurements ~5–10 Å. A structural
model of the core unit (PDB 3JA6) predicts that dimers are splayed ~20 Å apart in the
middle of the methylation subdomain and >60 Å at top of the HAMP domain. Thus we
sought an alternative approach to measure longer-range distances across the inter-dimer
interface.
Paramagnetic relaxation enhancements (PREs) result from dipolar interactions
between unpaired electron spins and surrounding nuclei. These far exceed internuclear
dipolar couplings, and can, therefore, affect

15

N nuclei up to 20 Å away from the

electron. Unpaired electrons from nitroxide radicals significantly enhance transverse
relaxation (T2) of nearby nuclei leading to peak broadening and signal attenuation. In an
NMR spectrum, PREs to a nitroxide radical are detectable as a decrease in peak
intensities (cartoon representation shown in Figure 5.1) that is directly proportional to the
inverse sixth power of the electron–nucleus distance. Therefore, by introducing an
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unpaired electron at a specific site within the receptor, structural constraints can be
obtained on a length scale consistent with the distances we aim to probe.

Figure 5.1. Nitroxide radicals enhance T2 relaxation, leading to signal attenuation.
Reduction in peak intensity occurs for resonances in close proximity to a paramagnetic
center compared to a diamagnetic center. The reduction corresponds to the PRE, which is
proportional to the electron–nuclear distance by the inverse sixth power.
As shown in Figure 5.2, paramagnetic tags are easily introduced into proteins
through site-directed spin labeling (Hubbell and Altenbach, 1994a, 1994b) in which a
thiol-specific label such as the nitroxide radical MTSL [(1-oxyl-2,2,5,5-tetramethyl-Δ3pyrroline-3-methyl)methanethiosulfonate] (Berliner et al., 1982) reacts with a unique
cysteine on the protein of interest. The first section of this chapter describes key features
of the method and yields of site-directed spin labeling applied to the cysteine mutant
S487C of the CF4E receptor. This site was chosen to address a number of criteria: (1)
S487 is located near the top of the methylation subdomain (Figure 5.3) in order to probe a
distance anticipated to show the largest measurable change upon the proposed expansion
(S487 faces the inside of the trimer of dimers, with ~18–20 Å interdimer distance from
the S487 hydroxyl protein to the backbone, (2) S487 is predicted to be solvent exposed,
leading to improved labeling efficiency, and (3) S487C has previous been shown to retain
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60% specific kinase activity and CheA/CheW binding compared to WT CF4E
(Mudiyanselage et al., 2013).

Figure 5.2. Structure of the nitroxide spin label (1-oxyl-2,2,5,5-tetramethyl-Δ3-pyrroline3-methyl)methanethiosulfonate (MTSL). Introducing it site-specifically is accomplished
by reacting with free unique cysteine thiols on a protein. This figure is modified from
(Jaroniec, 2012).

Figure 5.3. The location of initial spin label site (S487) is shown on the structural model
of the trimer of dimers. (A) Top down and (B) side view are colored with the N-helix in
light gray and C-helix in black. The spin label site (red sphere is S487 hydroxyl proton,
shown on one monomer for clarity) resides near the top of the methylation subdomain
facing the inside of the trimer of dimers (methylation sites shown as magenta spheres).
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This chapter presents NMR data comparing spin-labeled and non-spin-labeled
CF4E assembled on vesicles. Our results confirm that PREs are detectable in our system
and provide a platform, upon further experimental refinement, to obtain the first
structural restraints in the membrane-proximal region of chemoreceptors in functional
and native-like arrays.

5.2. Results and Discussion
5.2.1. Spin labeling CF4E.S487C yields 75% efficiency and is non-perturbing
Site-directed spin labeling typically utilizes an excess of spin label over protein
(typically 5–20 mol spin label/mol protein) that is subsequently removed by gel filtration
chromatography or desalting (Hubbell and Altenbach, 1994b). Site-directed spin labeling
of cysteines competes with formation of disulfide cross-linked protein dimers, which
cannot be spin labeled. Therefore, an important first step to maximize labeling efficiency
is to reduce any cross-linked protein prior to the addition of spin label. In solution,
CF4E.S487C is approximately 40% dimer (Figure 5.4A), but that is reduced to <1%
following incubation with 2 mM TCEP for 30 min at 25°C. Importantly, TCEP is
removed immediately before the addition of MTSL, as a reducing environment inhibits
successful spin labeling.

87

Figure 5.4. Non-reducing SDS-PAGE analysis enables quantification of CF4E.S487C
dimer fractions. (A) CF4E.S487C in the absence (–) or presence (+) of 2 mM TCEP,
added after protein purification. As quantified from ImageJ, treatment with TCEP for 30
min fully reduces all dimers. (B) Removal of TCEP followed by an overnight spin
labeling incubation at 4°C, U-15N-CF4E.S487C results in ~25% dimer. Gel samples were
prepared by quenching additional dimer formation with 10 mM NEM and gel sample
buffer immediately prior to boiling.
Following optimization, we found that eluting CF4E.S487C from the desalt
column for TCEP removal directly into a tube containing an excess amount of MTSL led
to the most monomer retention by SDS-PAGE. Unfortunately, we were unable to
implement an EPR-based method to measure spin label efficiency, as our results were not
reproducible. Instead, we used a combined approach: SDS-PAGE was used to quantify
monomer and dimer fractions, followed by ESI-MS analysis which was used to
distinguish unlabeled CF monomer from MTSL-labeled CF monomer by mass.
With the ultimate goal of PRE measurements by NMR, we isotopically labeled
CF4E.S487C with uniform

15

N, prior to MTSL-labeling. As seen in Figure 5.4B,

approximately 25% dimer is retained following the spin labeling protocol (section 2.8.2).
ESI-MS analysis of U-15N-CF4E.S487C + MTSL reported a single mass corresponding
to CF + MTSL, indicating 100% labeling yield of the monomer fraction. We therefore
conclude a final spin labeling efficiency of 75% was achieved for U-15N-CF4E.S487C.

88

To monitor the effects of spin labeling on protein function, we measured kinase
activity and assembly (with templating vesicles) of CF4E.S487C before and after
treatment with MTSL. The results presented in Figure 5.5 clearly indicate normal activity
and complex formation (shown in 5.5B for MTSL-labeled U-15N-CF4E.S487C).

Figure 5.5. MTSL-labeled U15N-CF4E.S487C has normal activity and binding. (A)
Spin-labeled and unlabeled U-15N-CF4E.S487C assembled on vesicles with 6 uM CheA
and 12 µM CheW exhibit kinase activity similar to typical CF4E activities of ~7 s–1. (B)
Sedimentation assay with a non-reducing gel shows the total (T), supernatant (S) and
pellet (P) lanes of the MTSL-labeled complexes from (A). Combined, 75% monomeric
CF (CFm) and 25% dimeric CF (CFd) are fully incorporated into complexes with CheA
and CheW at a stoichiometry of 6 CF (monomer + dimer): 1.1 CheA: 1.7 CheW. The
highest molecular weight band present in T and S lanes may be an impurity, nonfunctional CF trimers, or CF + CheA cross-links since CheA contains multiple cysteines.
However, it not present in complexes, as it is absent in the pellet. Gel samples were
prepared by quenching additional dimer formation with 10 mM NEM and gel sample
buffer immediately prior to boiling.
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5.2.2. Paramagnetic relaxation enhancements (PREs) observed by 1D 15N NMR
To test for PREs, we assembled spin-labeled and non-spin-labeled U-15NCF4E.S487C into complexes with templating vesicles. Figure 5.6 compares the 1D

15

N

cross polarization (CP) spectra of the non-spin-labeled (black) with MTSL-labeled (red)
complexes. These spectra were collected using identical parameters (see section 2.8.4)
and the samples notably contain precisely the same amount of CF (286 nmol). The largest
peak (centered at 121 ppm) corresponds to the bulk of backbone and side chain nitrogen
signals. However, some resonance assignments were possible for nitrogens with unique
chemical shifts (Table 5.1).
The MTSL-labeled spectrum clearly demonstrates PREs, seen as a reduction in
signal intensities for backbone and some side chain signals. To generate a difference
spectrum (green), the red spectrum was subtracted from the black spectrum. The intensity
of the difference spectrum was multiplied two-fold to facilitate visualization, clearly
showing all positive peak differences. This indicates the MTSL-labeled spectrum has a
globally lower intensity than the non-labeled spectrum. Notably, the structural model
predicts that no Lys are within 20 Å of the hydroxyl proton of S487, which is consistent
with the NMR spectra that show no change in the Lys signal intensity (the difference
spectrum at 33 ppm is flat). Any free MTSL would presumably cause signal attenuation
throughout the protein, including some of the 8 Lys located in the methylation and
signaling subdomains of the receptor.

Thus the observed difference spectrum is

consistent with PREs caused by the MTSL bound specifically to S487C on CF4E.
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Figure 5.6. PREs are observed for MTSL-labeled U-15N-CF4E.S487C. The PRE
difference spectrum (green) between non-MTSL-labeled (black) and MTSL-labeled (red)
kinase-on arrays is consistent with a decrease in signal intensity due to PREs from MTSL
bound to S487C. These 1D 15N CP spectra were collected as described in section 2.8.4.
Resolved nitrogen sidechain and Gly backbone resonances are labeled according to their
predicted chemical shifts (also in Table 5.1). The inset table lists the number, residue
type, and interface location of resolvable nitrogen signals predicted to be within 20 Å of
the hydroxyl proton of S487C. These predictions are from the structural model of the
trimer of dimers made by docking crystal structures of receptor fragments into PEGmediated array EM density (courtesy of Ariane Briegel, and shown in Figure 5.7).
Table 5.1. Predicted 15N chemical shifts for α-helix resonancesa
15

a

N Location

Ser

Thr

Asn

Gln

Gly

Arg

Lys

Backbone

114.8

115.3

117.6

118.6

107.3

118.9

119.9

Side chain

-

-

113

112

-

85 (Nε)
73 (NH1/2)

33

Resonance assignments based on (Wang and Jardetzky, 2002)
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Figure 5.7. Predictions of resolved nitrogens within 20 Å of S487C-MTSL. The top
down view of the structural model illustrates the unique nitrogens near the spin label site
(red sphere, shown on one monomer for simplicity) including intradimer: Gly (cyan), Arg
(blue), and Asn (purple), and interdimer: Gln (orange).
The largest signal attenuations observed in the 1D

15

N CP spectra (Figure 5.6)

unsurprisingly occur in the backbone region. As previously mentioned, the closest nuclei
to the unpaired electron will experience the largest PRE. Beyond backbone nitrogens,
there are a number of potentially resolvable side chain nitrogens that are predicted to be
within 20 Å of S487 based on the structural model of the Tar trimer of dimers. Figure 5.7
illustrates the nitrogens within 20 Å of S487 with unique chemical shifts (Table 5.1).
Most significantly, there are four Gln Nε (two on each opposing dimer) predicted to be
18 Å from S487. Since the 1D spectra do not resolve the Gln side chains from Asn (112
vs 113 ppm), we cannot determine whether the PRE observed for the Gln/Asn peak is due
to both, or just the intradimer Asn.
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5.3. Summary and Conclusion
In this chapter, the feasibility and utility of site-directed spin labeling to obtain
paramagnetic relaxation enhancements in functional chemoreceptor arrays was
demonstrated. Using thiol-chemistry, a paramagnetic spin label (MTSL) was successfully
attached to the unique cysteine S487C of CF4E to a final yield of 75% spin-labeled, as
measured by SDS-PAGE and ESI-MS. Together, the kinase activity and sedimentation
data show that spin label incorporation does not perturb function or assembly.
The NMR spectra obtained for U-15N-CF4E.S487C arrays with and without
MTSL confirm our ability to detect PREs, which are observed as signal attenuation of
nuclei in close proximity to the unpaired electron of the nitroxide radical. However, these
data clearly present a challenge moving forward: the low resolution 1D

15

N CP NMR

limits resonance specificity and sensitivity. Our ultimate goal is to obtain interdimer
distance restraints in a region of the receptor lacking high-resolution structural
information. This is particularly difficult given that the magnitude of PREs (i.e. the signal
decrease) drops at the longer distances we aim to measure (Jaroniec, 2012). Using PREs
to test the proposed signaling-related expansion (Besschetnova et al., 2008) poses an even
greater challenge, as it requires comparing difference spectra of samples prepared in the
kinase-on and kinase-off state. At the long-range distances needed to probe the expansion
hypothesis, it’s entirely possible the magnitude of PREs is too small to be resolved.
Therefore, we have devised strategies to improve specificity and sensitivity in order to
test our models and quantitatively measure interdimer distances.
We have devised a combined mixed labeling scheme and site-specific NMR
experiments that will further simplify the observed spectra. This approach involves
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assembling arrays containing a mixture of cross-linked dimers of U-13C-15N-CF4E.S272C
and natural abundance MTSL-labeled CF4E.S487C. Cross-linking CF4E dimers at
S272C (orange spheres in blue dimers of Figure 5.8) prevents dimer exchange and has
been shown to retain ~80% activity (Mudiyanselage et al., 2013). Therefore, this mixed
labeling scheme essentially filters out resonances from intradimer PREs given the low
13

C and 15N abundance without isotopic labeling of CF4E.S487C. Importantly, we must

take into account the distribution of possible trimer of dimer permutations. Assuming a
50:50 random mixture, 12.5% will contain only natural abundance MTSL-labeled
CF4E.S487C dimers and 12.5% only isotopically labeled CF4E.S272C. The remaining
75% will be mixed trimers, split equally between one inner MTSL label per trimer
(shown in Figure 5.8) and two per trimer. This labeling strategy gives exclusively
interdimer PREs and can be used to measure distances in 1D spectra, so extensive signal
averaging will enable us to detect small changes from PREs.
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Figure 5.8. Structural model of the trimer of dimers illustrates proposed approach for
interdimer distance measurements. The mixed labeling scheme involves assembling
arrays containing natural abundance CF4E.S487C (± MTSL, red sphere) shown in gray
and black, and U-15N, 1-13C-Val-CF4E.S272C shown in blue (S272C cross-links, orange
spheres). The unique dipeptide VQ490 (Q490 backbone N shown in yellow) is predicted
to be 18 Å from the hydroxyl proton of S487C.
While not quantitative at this stage, we have demonstrated measurable PREs to
MTSL-labeled S487C, probing the membrane-proximal region of the chemoreceptor
cytoplasmic domain in functional complexes. We have designed a feasible strategy to
measure quantitative PREs and provide structural constraints in this poorly understood
region of the receptor. This work has set the stage for future studies aiming to test the
proposed expansion model of signal transmission. Moreover, it will define structural
features of the receptor in the context of the array. It is widely applicable to any site that
can be mutated to cysteine throughout the receptor, to further constrain the structure.

95

CHAPTER 6
SUMMARY AND RECOMMENDATIONS
6.1. Summary of Findings
The main objective of this study is to probe the functional architecture and
assembly governing bacterial chemotaxis array formation in order to elucidate molecular
mechanisms of kinase regulation. To accomplish this, a metal-mediated assembly
strategy was developed to recapitulate the activity and structure of native chemoreceptor
arrays using aspartate receptor cytoplasmic fragments (CF). In this method, divalent
metals including Ni(II), Zn(II), and Co(II) bind to monomeric CF N-terminal His-tags,
which sufficiently stabilizes receptor dimers to promote ternary complex formation with
CheA and CheW. Activity measurements show that metals promote kinase-on state
assemblies of CF4Q, while metals combined with the crowding agent PEG drive
assembly of CF4E into the kinase-off/methylation-on state. Furthermore, electron
cryotomography (ECT) show these assemblies retain native-like architecture of the
canonical 12 nm center-to-center extended hexagonal lattice.
Metal-mediated assembly has enabled a deeper understanding of the relationship
between the array and kinase activation. Thus, a number of complementary principles
emerge from this work. First, we found that receptor dimerization with metal—observed
by size exclusion chromatography (Figure 3.9)—is sufficient to drive assembly of
complexes with CheA and CheW. This is consistent with results indicating that cysteine
cross-linked receptor dimers form sedimentable complexes with CheA and CheW in the
absence of stabilizing agent such as vesicles, PEG, or metal (Haglin, Li, and Kashefi,
unpublished observations). We did not, however, observe discrete trimers of receptors
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dimers by SEC. Instead, dimers form large oligomers, aggregates, and fibrils (Figure
3.10) in the absence of CheA and CheW. Remarkably, the metal-induced aggregation is
at least partially reversible; kinase activity is restored to aggregated His-tagged CF upon
the addition of CheA and CheW. Thus, ternary complex formation is highly favored in
the presence of metal.
The second principle that emerges is that allosteric interactions beyond the core
signaling unit contribute to fully activating the kinase. Kinetic analysis of the metalmediated assembly process using kinase activity and sedimentation (Figure 4.1), and SEC
(Figure 4.5) indicate CheA and CheW fully incorporate into complexes prior to the onset
of full kinase activity. Moreover, a distinct size shift to larger complexes at later
assembly times points (1–4 h) coincides with maximal activity. We cannot discern the
size of the initially smaller complexes, but they are large enough to sediment and clearly
form prior to assembly of the fully extended array. Since no further CheA or CheW binds
upon assembly into the extended array and measured stoichiometries are consistently
6:1:2, we conclude that core units contain four CheW in which two are bound strongly to
receptor and CheA, and two bound weakly to receptor alone (Figure 4.7). Importantly,
our results suggesting important allosteric interactions within the array are directly at
odds with reports that single core units prepared with intact receptors reconstituted into
nanodiscs are capable of all chemosensory functions to the same degree as native
membrane-bound arrays (Boldog et al., 2006; Li and Hazelbauer, 2011; Li et al., 2011).
However, we note that their core units are missing extra CheW due to extensive washing.
Proposed to provide array integrity as a CheW-only ring (Briegel et al., 2012; Liu et al.,
2012), perhaps excess CheW plays a role in preserving optimal array assembly and
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symmetry of the alternating CheA/W patterning best observed for in vivo arrays (Briegel
et al., 2014a).
Taken together, these outcomes shed light on a correlation between
chemoreceptor array size, array integrity, and kinase activity. Previously, it was observed
that the density of CF4E on templating vesicles was coupled to both kinase activation and
receptor methylation. Concurrently measured FRET efficiencies between receptor Cterminal tails suggested an expanded or dissociated state at lower receptor density
(Besschetnova et al., 2008). Additionally, reconstituted intact receptors at multiple
densities maintained similar ligand affinity, thus ruling out receptor dissociation
(Sferdean et al., 2012). These data lead to a proposed ligand-induced expansion model
(Figure 1.4). However, in light of the evidence presented in this study that low kinase
activity correlates with smaller arrays, we offer an alternative perspective that could
equally describe the observed activity density dependence: at low densities, receptor core
units are stably assembled but scattered and activate the kinase with less efficiency; high
receptor densities exhibit increased kinase activity as a result of achieving a fully packed
hexagonal lattice. The last section of this study established an approach to test these two
interpretations. The ligand-induced expansion model predicts the greatest trimer of
dimers distance change would occur nearest the membrane. As such, we aimed to collect
long-range structural measurements and constrain the trimer of dimers structure in the
membrane-proximal region. In comparing kinase-off and kinase-on assembled arrays
(either by density or mutation), an observed difference in trimer distances would confirm
an expansion whereas no change in distance would suggest core units are scattered at low
density.
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To measure interdimer distances and test the expansion model, we initiated a
paramagnetic relaxation enhancement (PRE) solid-state NMR approach. The data
presented in Chapter 5 indicate incorporation of the nitroxide paramagnetic spin label
(MTSL) at S487C of CF4E yields high labeling efficiency (75%) and does not perturb
activity or array assembly. Furthermore, a comparison of 1D

15

N NMR spectra with or

without spin label demonstrates PREs consistent with predictions from the trimer of
dimers structural model. Since quantitative distance measurements were not immediately
obtainable with a uniform

15

N-labeling scheme, we developed proposals to further

improve our sensitivity and specificity, as discussed in section 5.3.

6.2. Recommendations
A number of interesting questions emerge from this study. First, the role of excess
CheW in core complexes and the extended array remains unclear due to conflicting
observations. On one hand, Studdert and coworkers reported that overexpressing WT
CheW or high-receptor affinity mutants of CheW interfered with trimer formation,
clustering, and chemotactic ability (Studdert and Parkinson, 2005; Cardozo et al., 2010).
Conversely, Maddock et al. found normal polar clustering of chemoreceptors in the
absence of CheA, suggesting CheW alone is sufficient to drive assembly of complexes
(Maddock and Shapiro, 1993). The repeating protein–protein contacts between
CheA/CheW and CheW/Receptor anchor the three components of the core unit and the
extended array. These interfaces have been defined through both in vitro (Natale et al.,
2013; Piasta et al., 2013) and in vivo (Pedetta et al., 2014) disulfide crosslinking
experiments, NMR (Vu et al., 2012; Wang et al., 2012a), and x-ray crystal structures
(Briegel et al., 2012; Li et al., 2013). In an ECT-derived model, CheW within the CheW99

only ring interact with adjacent receptors through strong hydrophobic interactions similar
to those for CheA-P5 to receptors (Liu et al., 2012). Notably absent from the literature,
however, is a detailed study of the CheW/CheW interactions within the functional array.
A detailed disulfide mapping of CheW–CheW contacts for arrays would shed light on
both the type and strength of these interactions.
We have demonstrated in this study that excess CheW is likely a component of
the chemosensory core unit and therefore an integral part of the array as CheW-only
rings. Is it possible that by satisfying all available receptor binding sites, excess CheW
enhances assembly? One such possibility is that excess CheW helps drive the alternating
CheA/W and CheW-only ring patterning observed optimally for in vivo arrays (Briegel et
al., 2014a). We could test this by assembling either PEG or metal arrays with both low
and high CheW concentrations in the assembly, and analyze the effects on kinase
activity, assembly (by SEC), and array structure (by ECT).
While the metal-mediated assembly method has found great use and applicability
for bacterial chemotaxis arrays, we ultimately feel it will find a greater use in other large
multiprotein complex systems. Given the extraordinarily crowded conditions of the cell
(Ellis, 2001), a vast number of important biological processes are performed by protein
dimers or protein complexes (Alberts, 1998; Marsh and Teichmann, 2015). Fully
understanding these processes is often accomplished through in vitro recapitulations of
native systems. Our in vitro strategy is particularly well suited for proteins that dimerize
as part of their assembly process, such as many other transmembrane signaling proteins.
The mechanism of metal assembly relies on His-tags, which are widely used and easily
incorporated into proteins on the termini and within. To conclude, we feel that this work
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has begun to unravel integral functional and architectural features of chemoreceptor
arrays, and hope that applying this method to other more complex systems can make
similar advances.
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APPENDIX
UNILAMELLAR VESICLE ASSEMBLY OPTIMIZATION
Template-directed vesicle assembly of chemoreceptor signaling complexes was
developed as a simplified approach to study the receptor cytoplasmic fragment (CF) in
functional complexes with CheA and CheW (Shrout et al., 2003). Mixed lipid vesicles
containing a nickel-chelating lipid (DOGS-NTA-Ni2+, henceforth called DOGS for
simplicity) were used to guide the assembly of histidine-tagged CF onto the outer leaflet
of the lipid bilayer. Preparation of unilamellar vesicles is critical for achieving a known
membrane surface area that is fully occupied by hexagonally organized active complexes.
Active signaling complexes form under a variety of lipid and protein concentrations, but
retaining native-like array hexagonal geometry and protein stoichiometry requires finetuning. To address these issues, this appendix describes (1) the implementation of a
fluorescence-based assay to measure vesicle lamellarity, and (2) optimization of protein
concentrations to achieve maximal kinase activation and native-like stoichiometry (6
CF:1 CheA:2 CheW) on these unilamellar vesicles.
A1. Fluorescence Lamellarity Assay
The preparation of lipid vesicles, as described in Chapter 2 (Section 2.2), includes
freeze/thaw cycles following lipid rehydration in order to promote formation of
unilamellar vesicles. Prior to including this in the protocol, our vesicle preparations were
heterogeneous mixtures of unilamellar, bilamellar, and multilamellar, as seen by ECT
(Figure A.1).
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Figure A.1. Tomographic slices of binary lipid vesicles containing DOPC and DOGSNTA-Ni2+ show extensive lamellae layering. These multilamellar vesicles (MLVs) were
extruded to 100 nm (see Chapter 2) but did not undergo cycles of freeze/thaws. ECT
kindly provided by Dr. Ariane Briegel.
We employed a fluorescence-based assay to monitor the integrity of our vesicle
preparation and determine vesicle lamellarity (McIntyre and Sleight, 1991; Angeletti and
Nichols, 1998; Heider et al., 2011). For this experiment, vesicles were prepared as
described in Chapter 2 (including freeze/thaw cycles) with the addition of the fluorescent
lipid

DOPE-NBD

(1,2-dioleoyl-sn-glycero-3-phosphethanolamine-N-(7-nitro-2-1,3-

benzoxadiazol-4-yl) such that the final DOPE-NBD concentration was 1% of the total
lipid. We assume that the high degree of miscibility of these ternary mixtures of lipids
(DOGS + DOPC + DOPE-NBD) promotes equally dispersed NBD on the inner and outer
leaflets. Vesicles were diluted to ~100 µM lipid for a final NBD concentration of ~1 µM,
and placed in a fluorometer that is setup to perform a time-based experiment (~10
minutes) with NBD excitation and emission wavelengths at 460 nm and 535 nm,
respectively. As shown in Figure A.3, the first 200 seconds of recording was sufficient to
determine initial intensity and photo bleaching effects. Then, the membrane impermeable
NBD fluorescence quencher dithionite was added to a 1000-fold excess over the NBD
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(for example, 1 mM dithionite added to 1 µM DOPE-NBD that is at 1% concentration of
the 100 µM vesicles), and fluorescence levels recorded for an additional 200 seconds.
The drop in fluorescence was then used to estimate the number of lamellae present in the
vesicle population. Following quenching, the remaining fluorescence of predominantly
unilamellar vesicles should be ~50% of the initial intensity, originating from the interior
bilayers of the vesicles (Figure A.2 and A.3). Quenching to less than 50% of initial
fluorescence may indicate the presence of leaky vesicles. Quenching to levels between 50
and 100% may indicate the presence of multilamellar vesicles.

Figure A.2. Cartoon representation of outer leaflet quenching of DOPE-NBD. NBD
labeled lipids are colored in red. Upon addition of dithionite (S2O42–), only inner leaflet
DOPE-NBD lipids retain fluorescence. Reprinted (adapted) with permission from (Heider
et al., 2011). Copyright 2011 American Chemical Society.
To solubilize the vesicles, Triton X-100 was added above its critical micelle
concentration of 0.22 mM (Tiller et al., 1984) and at least a 4-fold excess over total lipid
concentration (for example, 400 µM Triton X-100 added to 100 µM vesicles). The return
to baseline fluorescence intensity indicates complete vesicle disruption and full
quenching of the inner leaflet DOPE-NBD.
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Figure A.3. Relative fluorescence intensity changes upon outer leaflet quenching. This
plot of relative fluorescence intensity is from a population of vesicles showing fractional
intensity loss as a result of quenching the outer leaflet NBD with dithionite. A 100 µM
solution of 59% DOPC, 40% DOGS-NTA-Ni2+, and 1% DOPE-NBD was placed into a
cuvette and fluorescence measured over time (excitation at 460 nm and emission at 535
nm). At approximately 200 s, addition of sodium dithionite (Na2S2O4) quenches NBD
fluorescence leading to a drop in relative intensity to ~50%, indicating a predominantly
unilamellar vesicle population. Vesicles are fully solubilized upon the addition of 400
µM Triton X-100 at 400 s. The slow fluorescence decreases are due to photo bleaching
effects.
A2. Vesicle Assembly Protein Concentration Optimization
This section describes the optimization of protein conditions in order to fully
maximize the vesicle surface area occupied by hexagonal arrays. We used kinase activity
and stoichiometry (optimal is 6 CF: 1 CheA: 2 CheW) measured in a sedimentation
binding assay to determine optimal protein concentrations for vesicle assembly (see
Chapter 2 for details). Previously, Weis and coworkers utilized vesicles at a total lipid
concentration of 580 µM at a 1:1 ratio of DOPC:DOGS (Shrout et al., 2003; Montefusco
et al., 2007). These experiments used 30 µM CF (≈1/10 of DOGS concentration) for
complete binding of CF to DOGS, and used limiting concentrations of CheA (1.2 µM),
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and CheW (5 µM) so that all of CheA and CheW would be bound to CF. Koshy
subsequently identified conditions with excess CheA and CheW (30 µM CF, 6 µM
CheA, and 12 µM CheW) with maximal activity on 580 µM vesicles (optimization
detailed in (Koshy, 2013)) so that all of the CF would be incorporated into complexes
with CheA and CheW.
In addition to improving our preparation of unilamellar vesicles, we increased the
total lipid concentration to 725 µM, maintaining 290 µM DOGS, in order to provide
sufficient surface area for full hexagonal arrays of 30 µM CF. Thus, the optimization of
new CheA and CheW concentrations was needed. To do so, we simultaneously changed
CheA and CheW concentrations while keeping 30 µM CF (both CF4E and CF4Q) and
725 µM vesicle constant. CheA and CheW conditions at different ratios ranging from 6–
24 µM were compared. For simplicity throughout this section, these conditions are
labeled and referred to by the assembly concentration ratios of CheA to CheW (e.g. 6:12
means 6 and 12 µM CheA and CheW, respectively), with 30 µM CF in each assembly,
but omitted in the label. These values are different than the measured stoichiometries of
the complex determined after assembly from the pellet ratios in the sedimentation assay
(e.g. 6:1:2 is 6 CF to 1 CheA to 2 CheW).
Optimal conditions for both CF4E and CF4Q assembly on 725 µM vesicles were
chosen based on both the activity and complex stoichiometry. Many of the CheA and
CheW concentrations tested promote similar activities, and likewise many assemblies had
acceptable stoichiometries. These data were collected over the course of 2–3 days each
for CF4E and CF4Q, and fresh vesicles were prepared and used no more than one day
later. Replicate assembly ratios were prepared to carry over multiple days and account for
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day-to-day variability. However, these replicates were reproducible, and no further
correction of activities or ratios was necessary. For CF4E, 8:12 and 12:20 produced the
highest activity with approximately 6:1:2 stoichiometries (Figure A.4.A and Table A.1).
While 6:12 had the highest activity overall, this sample had only 2.9 µM CheA bound
and the stoichiometry was 6:0.6:1.0, and thus below native levels. These conditions may
be useful, however, if such stoichiometries were desired. CF4Q assemblies were typically
more active than CF4E with greater CheA binding (Figure A.4.B and Table A.2). 12:24
produced the highest activity and was therefore chosen as the optimal assembly condition
for CF4Q. While this assembly had an elevated complex stoichiometry of 6:1.7:2.4, we
note that most CF4Q assemblies were similarly higher than the native 6:1:2.
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Figure A.4. Optimization of CheA and CheW concentrations for maximal kinase activity
with vesicle assembly. CF4E (A) and CF4Q (B) were each assembled at 30 µM with
varying concentrations of CheA and CheW that correspond to labels (e.g. 6:12 means 6
and 12 µM CheA and CheW, respectively). Vesicle concentrations were kept constant at
725 µM total lipid (with 290 µM DOGS). Total (black bars) and specific (gray bars)
kinase activities are averages of two replicates and error bars indicate ± one standard
deviation. Data are also listed in Table A.1 for CF4E, and A.2 for CF4Q, with
corresponding [CheA]bound and pellet stoichiometries.

108

Table A.1. Kinase activities, CheA binding, and complex stoichiometries in CF4E
vesicle assembly optimization
CheA:CheW
(µM)a

Total
Activity (s–1)b

Specific
Activity (s–1)c

Bound
CheA (µM)

Stoichiometry
(CF:CheA:CheW)

6:6

2.35 ± 0.07

4.87 ± 0.15

2.9

6:0.4:0.5

6:12

5.13 ± 0.04

11.40 ± 0.08

2.7

6:0.6:1.0

8:12

3.38 ± 0.06

6.48 ± 0.12

4.0

6:0.8:1.2

8:16

4.31 ± 0.01

8.61 ± 0.01

4.0

6:0.9:1.7

10:20

3.29 ± 0.09

5.58 ± 0.15

5.9

6:1.5:1.5

12:8

1.69 ± 0.01

5.19 ± 0.02

3.9

6:0.9:0.8

12:12

2.62 ± 0.06

7.32 ± 0.17

4.3

6:1.1:1.3

12:16

3.11 ± 0.14

6.33 ± 0.29

5.9

6:1.5:1.6

12:20d

3.92 ± 0.10

9.41 ± 0.25

5.0

6:1.4:1.7

12:24

3.29 ± 0.07

4.07 ± 0.09

9.7

6:1.7:2.4

16:8

1.42 ± 0.01

5.15 ± 0.02

4.4

6:1.1:1.0

16:12

1.93 ± 0.01

6.67 ± 0.03

4.6

6:1.2:1.3

18:18

2.42 ± 0.11

8.52 ± 0.37

5.1

6:1.4:1.6

a

30 µM CF4E, 725 µM vesicles (435 µM DOPC and 290 µM DOGS-NTA-Ni2+) and
varying concentrations of CheA and CheW (listed) in each assembly.
b
Kinase activity per total CheA in assembly
c
Kinase activity per bound CheA in assembly
d
Optimal conditions chosen for CF4E based on high activity, CheA binding, and
stoichiometry.
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Table A.2. Kinase activities, CheA binding, and complex stoichiometries in CF4Q
vesicle assembly optimization
CheA:CheW
(µM)a

Total
Activity (s–1)b

Specific
Activity (s–1)c

Bound
CheA (µM)

Stoichiometry
(CF:CheA:CheW)

6:6

4.32 ± 0.25

7.20 ± 0.42

3.6

6:0.8:0.8

6:12

3.30 ± 0.37

5.82 ± 0.65

3.4

6:1.2:1.2

12:12

4.60 ± 0.13

8.37 ± 0.23

6.6

6:1.8:1.9

12:18

4.31 ± 0.07

8.08 ± 0.14

6.4

6:1.5:2.2

12:20

5.38 ± 0.25

9.17 ± 0.43

7.0

6:1.7:1.8

12:24d

6.54 ± 0.02

10.89 ± 0.03

7.2

6:1.7:2.4

14:20

3.87 ± 0.04

6.77 ± 0.07

8.0

6:1.7:1.7

16:24

4.39 ± 0.02

7.47 ± 0.03

9.4

6:2.0:1.6

18:12

2.32 ± 0.10

5.23 ± 0.03

8.0

6:1.8:1.7

18:18

2.53 ± 0.03

6.81 ± 0.07

6.7

6:1.6:2.0

18:24

3.21 ± 0.05

8.76 ± 0.13

6.6

6:1.8:2.5

24:12

1.92 ± 0.01

8.07 ± 0.04

5.7

6:1.3:1.1

24:18

2.00 ± 0.01

10.02 ± 0.01

4.8

6:1.4:1.4

a

30 µM CF4Q, 725 µM vesicles (435 µM DOPC and 290 µM DOGS-NTA-Ni2+) and
varying concentrations of CheA and CheW (listed) in each assembly.
b
Kinase activity per total CheA in assembly
c
Kinase activity per bound CheA in assembly
d
Optimal conditions chosen for CF4Q based on high activity, CheA binding, and
stoichiometry.
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